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Some procarcinogens, such as Polycyclic Aromatic Hydrocarbons (PAHs), are 
metabolized by Cytochrome P450I (CYPl) enzymes into ultimate carcinogens. CYPl 
gene transcription can be induced by Aryl Hydrocarbon Receptor (AhR) transactivation， 
I 
and PAHs are ligands of the AhR. Reduced biotransformation of carcinogens via direct 
inhibition on CYP enzyme activity or through inhibition on the AhR activation pathway 
is believed to be an important mechanism of cancer prevention. 
UDP-glucuronosyltransferases (UGTs) are Phase II enzymes, which have been 
recognized as carcinogen detoxifying proteins. These enzymes are highly expressed in 
the liver, and their activities can also be regulated both at the enzyme and gene 
transcription levels. Induction of the UGT enzyme activities is another pathway to 
avoid PAH-induced carcinogenesis. 
Chalcones are flavonoid derivatives that are abundantly present in nature from 
ferns to higher plants. Recent research has implicated their potentials in cancer 
prevention. However, the mechanisms involved are unknown. In this study, chalcone 
and five hydroxychalcones: 2'-hydroxychalcone, 2-hydroxychalcone, 
4-hydroxychalcone, 4,2',4'-trihydroxychalcone and butein 
(3,4,2',4'-tetrahydroxychalcone) were investigated for their effectiveness in inhibiting 
C Y P l A l & IB l enzyme activities and mRNA expressions in a human breast cancer 
cell model. Chalcones showed potent inhibitory effects on CYPlAl & IBl enzymes 
both at enzyme and gene transcription levels. Chalcones induced UGT enzyme activity 
in both MCF-7 and HepG2 cells, and they also increased U G T l A l gene expression in 
these cell lines. This is another pathway of chalcones to prevent carcinogenesis. 
Regarding estradiol hydroxylation activity, chalcone, 4,2'4'-trihydroxychalcone 
and butein could reduce 2-，4- & 16 a-es t radiol hydroxylase activities in MCF-7 cells 
and recombinant CYPl microsomes. Because of the implications of 4- & 16 a 




Monoterpenes are also natural compounds, which have been reported to prevent 
mammary carcinomas in rats. The present study showed that, both perillyl alcohol and 
limonene exhibited inhibitory effects on CYPlAl & IBl enzymes. However, the 
former was more potent than the latter. They also induced UGT enzyme activity in both 
MCF-7 and HepG2 cells. Moreover, perillyl alcohol was an effective inhibitor on 4- & 
16a-estradiol hydroxylation pathways. 
Lycopene, an important gradient from tomato, displayed its chemopreventive 
effects in both pathways: CYPlAl & IBl enzyme inhibition and UGT enzyme 














査耳酮类（chalcones )是一族黄酮类（flavonoids )的衍生物。从蕨类到高等 
植物，査耳酮在自然界里广泛存在。虽然近来的一些研究涉及到它们具有防癌的 
特性，但是具体的机制如何就不得而知了。以査耳酮（chalcone )和5种轻基査耳 
酮：2，一轻基査耳酮（2，-hydroxychalcone ) 2—轻基査耳酮（2-hydroxychalcone ) 
4 一轻基査耳酮（ 4 - h y d r o x y c h a I c o n e ) � 4,2',4' 一 三 轻 基 査 耳 酮 
(4,2‘,4‘-trihydroxychalcone )禾口紫柳花素（butein, 3,4,2‘,4‘-tetrahydroxychalcone ) 
为研究对象，本实验采用人类乳腺癌细胞模型，旨在探索他们对CYP1A1 & 1B1 
的_活性和其m R N A表达的抑制作用。这类物质在_活性和基因转录水平上都同 




白中的雌二醇2- , 4 -和16 a -轻基化 _的活性。由于 4 -和 1 6 a -轻基雌二醇涉及到 
有导致癌症的作用，査耳酮类的这一抑制作用可成为其防癌作用的一取代机制。 
一 f f i类是另一类被报道具有防止大鼠乳腺癌作用的天然化合物。本实验结果 




中的UGT酶活性。此外，紫苏乙醇还能有效地抑制雌二醇的4-和16 a -轻基化路 
径。 
番®红素（lycopene )是番琉中的一种重要成分，在本实验中其也被证明通过 





CHAPTER 1 GENERAL INTRODUCTION 
I • The essential factors relate to cancer 
a. Carcinogens 
Cancer is one of the leading causes of death in the human population and it is 
well known that environmental chemicals cause cancer. Breast cancer is the major 
cause of cancer death in women worldwide. Female descendants of migrants 
emigrated from low-risk (most Asian and developing countries) to high-risk (Western 
countries) experience breast cancer rate approaching to that of the host country 
(Willett, 2001). This observation strongly implicates that lifestyle is a major 
contributing factor to the development of the disease. Dietary and environmental 
causes may be responsible for up to 50% of breast cancer cases (Williams & Phillips， 
2000). 
Causes of cancer 




• Sexual behavior 
, • Alcohol 
Figure 1.1—Pie chart of different factors leading • Infection 
. • • Occupational exposure 
to cancer and their ratios. • uv/radiation 
• Pollution  
Polycyclic aromatic hydrocarbons (PAHs) are one group of chemicals formed 
when coal, wood, gasoline, oil, tobacco or other organic materials are burned 
(Comnel University Program on Breast Cancer and Environmental Risk Factors in 
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New York State, 2001). 7’ 12-Dimethylbeiiz[a]anthracene (DMBA) is a synthetic 
PAH that has been used extensively as a prototypical agent in mutation and cjincer 
research (Teel & Huynh，1998). Chlorinated hydrocarbons (CHCs), a heterogeneous 
group of man-made organic compounds, are also environmental contaminants that 
bioaccumulate and are detectable in human tissues. Epidemiological evidence 
suggests that the increased incidence of a variety of human cancers, such as breast 
cancers, might be attributed to the exposure of these agents (Badawi et al , 2000). 
Dietary factors, and dietary fat in particular, have held account for the large 
variation in breast cancer incidence around the world and the increases amongst 
migrants relocated from an undeveloping country to a developed country (Willett, 
2001). It has been estimated that diet can modulate cancer death rate by as much as 
35% (Lautraite et al.，2002). The incidence and mortality rates of breast cancer in the 
Western world are much higher than those in Asia where soybeans (a rich source of 
isoflavonoids) are an important part of the diet. Certain breast cancer patients in those 
Western countries appear to have a relatively low level of flavonoid intake and 
excretion (Helsby et al., 1998). Some scientists have also hypothesized that early 
exposure to soy in life would confer a "programming" effect on the tissue to render a 
permanent protection against breast cancer (Forum Symposium on Mechanisms of 
Action of Naturally Occurring 
Anticarcinogens, 1999). Flavonoids C H ^ 
constitute one of the largest groups 
of natural polyphenols and exert a 
broad range of biological activities 
in both plants and animals (Teel & 
Huynh, 1998). The dietary intake of 
flavonoids varies widely, and it has 
been estimated to be as high as 3 
Ig/day in the Asian countries Figure 1.2—Chemical structure of 
7， 12-dimethylbenz[a]anthracene 
(Ciolino et al., 1999). Dietary (dmBA). 
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flavones and flavonols are usually found in vegetables, fruits, teas and red wine; and 
flavanones, isoflavones and catechins in citrus fruits, beans and teas, respectively 
(Ashida et al., 2000). 
b. Carcinogenesis pathways 
Aryl hydrocarbons bind and activate the aryl hydrocarbon receptor (AhR)，and 
induce the transcription of a number of genes, namely the cytochrome P4501 enzymes. 
Inhibition of the metabolic activation of pro-carcinogens, whether through the 
AhR-mediated signal transduction pathway or direct enzyme inhibition, is believed to 
be an important mechanism in chemoprevention. The initiation phase begins with the 
activation of the procarcinogen by CYP enzymes. This generates metabolites with 
forms eliminatable by Phase II enzymes. Among them, the epoxides are highly 
electophilic and carcinogenic, and are capable of reacting with DNA and causing 
mutations (Ciolino & Yeh，1999b). 
c, DNA adducts formation and breast cancer 
Tissue samples from the breast cancer patients contained significantly higher 
levels of aromatic DNA adducts, and the cancer patients also had a significantly 
higher level of lipid peroxidation-related DNA adducts than controls (Li et al., 1999). 
A number of PAHs are potent mammary carcinogens in experimental bioassays. In 
vitro studies show that human breast epithelial tissue has an ability to metabolize 
PAHs to their ultimate DNA-attacking moieties (Rundle et al., 2000). The DMBA 
activation pathway is mediated by a cytosolic receptor, AhR, which can be converted 
to its high-affiiiity DNA-binding form upon activation (MacDonald et al.，2001). 
7 
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n . Cytochrome P4501 enzyme family 
a. CYP450 superfamily 
Cytochromes P450 (CYP) are a superfamily of enzymes, which are found in all 
forms of living organisms. In humans, they metabolize numerous exogenous and 
endogenous compounds into carcinogens (Barbiellini, 
httD://stardec.ascc.neu.edu/--bba/RES/P450/P450.htmy The liver is the main organ for 
xenobiotic metabolism and contains major CYPs (Sy et al., 2001). Variation in CYP 
expression is determined by hormonal status, diet, smoking, age, genotype, and drug 
exposure (Rodriguez-Antona et al.，2001). 
Figure 1.3Protein structure of CYPl enzyme. 
It shows the alpha-helix, beta-sheet and non-repetetive structures 
(Barbiellini, http://stardec.ascc.neu.edu/-bba/RES/P450/P450.html 
Cytochrome P450 is named after a strong maximum in the UV spectrum at 450 
nm when complexing with CO, and P stands for pigment. The P450 proteins are 
8 
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categorized into families and subfamilies according to their sequence similarities. 
Sequences that are greater than 40% identical at the amino acid level are grouped into 
the same family. Sequences that are greater than 55% identical are assigned to the 
same subfamily. There are now more than 1200 cytochrome P450 sequences known. 
Humans have 17 families of cytochrome P450 genes and 42 subfamilies. Among them, 
CYPl has 3 subfamilies, 3 genes， and 1 pseudogene (Barbiellini, 
httD://stardec.ascc.neu.edu/~bba/RES/P45Q/P450.htmY 
The principle physiological reaction of the P450 superfamily is catalyzed by 
monoxygenase. The catalytic reaction can be summarized as follows: 
RH+O2 + 2H + 2 e - R O H +H2O 
Where RH can be one of the possible substrates. The P450 protein incorporates 
one atom of molecular oxygen into the substrate and the other into water. The reaction 
takes place on the Fe^ "^  ion in the heme moiety found at the active site of all P450 
enzymes. Spectral evidence indicates that the heme Fe^ "^  is in a low-spin (LS) state in 
the substrate-free form of P450. However, in the catalyzing state, on binding of a 
substrate the Fe^ ^ is found to change to a high-spin (HS) state (Barbiellini, 
http://stardec.ascc.neu.edu/~bba/RES/P450/P450.htmy 
The shaped 
a the heme 
deep has 
been a channel 
be open some in 
the of 
the in 
the other half 
or 
structure I H B H H H H H H ^ H H I H H H H H I H I 
(Barbiellini, Figure 1 A 3 D structure of CYPl enzyme. It shows 






CYPlAl is of interest because it is one of the most active cytochrome P450 
enzymes in metabolizing PAH into active species. Formation of DNA adducts in these 
active species is thought to be the initial step in carcinogenesis (Morel & Barouki， 
1998). 
The human CYPlAl gene is located on chromosome 15 and is composed of 
seven exons and six introns with an mRNA of 2.8 kb in length (Murray et al.，2001). 
The 5’- upstream region of the human CYPlAl gene contains several 
xenobiotic-responsive elements (XREs) mediating the Ah response (Morel & Barouki， 
1998)，so its expression is highly inducible by environmental xenobiotics through the 
aryl hydrocarbon (Ah) receptor (Sy et al, 2001). 
CYPlAl is primarily extrahepatic, being expressed in only 2% of human livers 
(Zhang et al., 1995). 
Figure 1.5 
GRqP�-HSi:mLRK;KYGE>VFrLYLGPRFVVVVTGPEAVKEVIJDK： 











CYPIBI, which was not found until 1994, shares -40% homology with 
CYPlAl. CYPIBI protein in normal human tissues expresses at a very low level, but 
it is overexpressed in a variety of human tumor cells, and this has important 
implications for tumor development and progression (Murray et al.’ 2001). It is 
mainly found in extrahepatic steroidogenic tissues such as the ovary, the testis, and 
the adrenal gland and in steroid-responsive tissues such as the breast, the uterus, and 
the prostate (Chun et al.，2001). 
The human CYPIBI gene is located on chromosome 2 spanning approximately 
12 kb of DNA and is composed of three exons and two introns. The mRNA is 5.2 kb 
in length and the open reading frame begins at the 5’- end of the second exon, in 
contrast to other P450s, which all begin at exon 1. The predicted CYPIBI protein 
sequence has 543 amino acids (Murray et al, 2001). At least three different proteins 
are involved in the ligand binding, nuclear localization, and transcription enhancer 
activities of this protein complex (Sutter et al., 1994). 
CYPIBI possesses a greater capacity than CYPlAl in bioactivating a number of 
PAH procarcinogens (MacDonald et al” 2001). CYPIBI might also be involved in 
hormone-induced carcinogenesis, since it is able to metabolize estradiol to 
2-hydroxyestradiol and 4-hydroxyestradiol (Li et al., 2000). 
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in. Transactivation of CYPl enzymes by aryl hydrocarbon receptor (AhR) 
The mechanism of induction of CYPl gene transcription by PAHs involves 
ligand recognition and binding by the AhR, nuclear translocation and dimerization 
with the AhR nuclear translocator protein (ARNT). The nuclear heterodimer then 
recognizes and interacts with the xenobiotic response element (XRE), located in the 
promoter/enhancer regions of multiple AhR-responsive genes. The interaction occurs 
within the major groove of the DNA helix, and, therefore, leads to changes in 
chromatin structure and/or alterations in the basal transcriptional machinery，which 
results in the induction of gene expression (Badawi et al.，2000). 
Several inhibitors of CYPlAl transcription are known to function by binding to 
the ligand binding site of the AhR, blocking the binding of other ligands and thereby 
preventing AhR activation (Ciolino & Yeh, 1999a). 
PAHs 二 
A i : � 
\ ’ r^W _ 
Figure 1 . 6 C Y P l A l gene transactivation pathway induced by PAHs. 
(Whitlock, http://www, Stanford, edu/group/whitlock/prot-prot) 
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IV. Phase II enzyme UGT and cancer prevention 
UDP-glucuronosyltransferases (UGTs), which catalyze the conjugation of endo-
and exobiotics, are a superfamily of membrane-bound enzymes, localized inside the 
endoplasmic reticulum of cells (Fisher et al., 2000). UGTs catalyze the 
glucuronidation reaction, which represents a major pathway in Phase n drug 
metabolism (Guillemette et al., 2000). Thus, glucuro nidation may contribute to the 
elimination of CYP-mediated reactive intermediate metabolites, and prevents a toxic 
event (Yueh et al, 2001). UGTs play a major role in the detoxification of a diverse 
range of molecules, including carcinogens and biologically active endogenous 
compounds, such as steroid hormones (Guillemette et al” 2000). The detoxification 
pathways may also play a role in the defense against environmental mutagens by 
facilitating their removal from the cells prior to the initiation of the mutagenic event 
(Yueh et al” 2001). 
Based on sequence similarities, UGT forms can be divided into two families, 
UGTl and UGT2. UGTl is the drug-glucuronidating form, while UGT2 is the 
steroid-glucuronidating form (Emi et al, 1996). UGTl A and 2B are mainly expressed 
in the liver whereas the expressions of other UGT forms have been reported in 
extrahepatic tissues (Fisher et al.’ 2000). Additional studies suggest that UGTl A1 is a 
major contributor to estradiol-glucuronide formation. Individuals deficient in 
UGTl A1 present a 70% decrease in the glucuronidation of estradiol compared to their 
normal counterparts (Guillemette et al.’ 2000). 
Lig and-bound AhR also activates the transcription of a battery of detoxification 
enzymes such as UGT (Ciolino et al, 1998). Recent evidence has indicated that early 
down-regulation of the UGTs in premalignant and malignant tumor tissues but not 
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Figure 1.7 Phase I and Phase II enzyme reactions involved in biotransformation. 
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V. Estrogen metabolism and the hormone-dependent breast cancer 
a. Estrogen and breast cancer initiation 
Epidermiological studies and animal experiments have revealed that estrogens 
are carcinogenic. In humans, elevated circulating estrogen levels, caused either by 
increased endogenous hormone production or by therapeutic doses of estrogen 
mediations, increase breast and uterine cancer risk (Hiraku et al.，2001). Estrogens can 
cause cancer by stimulating cell proliferation and causing genotoxic damage, and they 
are highly mitogenic in hormone-sensitive tissues, such as the breast and the uterus 
(Hiraku. et al., 2001). 
I 
b. Estrogen Receptor (ER) 
Estrogen probably does not initiate the cellular changes that result in cancers, but 
k does stimulate the growth of cells that have taken the first steps toward uncontrolled 
proliferation. The hormone affects only cells that express nuclear proteins called 
estrogen receptors (Jordan, 1998). Many proliferation-mediated pathways initiated 
through the action of the estrogen receptor (ER) are well defined. The steroid-receptor 
complex interacts with sequence-specific estrogen response elements (EREs) in target 
cell chromatin to induce gene expression and to promote growth of target cells, such 
as breast epithelial cells and estrogen-dependent mammary carcinoma cells (Mobley 
& Bnieggemeier，2002). Estrogen, through receptor-mediated processes, affects the 
rate of cell proliferation. The proliferation enables the incorporation of genetic errors 
that leads to a malignant phenotype (Cavalieri et al., 2002). 
c. Estradiol hydroxylation pathways 
The genotoxic effects of estradiol could result from accumulation of potentially 
carcinogenic metabolites. Estradiol undergoes CYP-catalyzed hydro xylation to 
various catechol estrogens. 2-Hydroxylation is a major metabolic pathway in the liver, 
whereas 4-hydroxylation is dominate in extrahepatic organs susceptible to estrogens 
(Hiraku et al., 2001). Catechol estrogens show more potent carcinogenic effects than 
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estradiol. They caused Cu( II )-mediated oxidative DNA damage, including 8-oxodG 
formation, at nanomolar concentrations in the presence of NADH (Hiraku et al., 
2001). Therefore, catechol estrogens can be potent carcinogens and may participate in 
tumor initiation by causing DNA damage (Hiraku et al., 2001). Estrogen can be 
hydroxylated mainly at two positions, namely C-2 and C-16 a . The two hydroxylated 
metabolites differ significantly in their estrogenic potency. The 16 a 
-hydroxy-estrogen is a long-acting ligand with estrogen receptor and is more liable to 
cause cell proliferation; on the contrary, the 2-hydroxy metabolite is devoid of 
estrogenic activity and is also rapidly cleared from the circulation (Wong et al.，1998). 
The formation of 2-hydroxyestradiol is predominantly mediated by CYPlAl and 
CYP1A2, which also catalyze 4-hydroxylation to a lesser extent (Badawi et al., 2000). 
In human MCF-7 breast cancer cells, the formation of 4-hydroxyestradiol is catalyzed 
by CYPIBI. The elevated formation of 4-hydroxylated estrogens in estrogen 
targeting organs may increase the risk of hormone-induced oncogenesis and may also 
be a useful marker of hormone-induced tumors (Liehr & Ricci, 1996). When 
compared with normal breast tissues, elevated ratios of 4-hy(iroxyestradiol to 
2-hydroxyestradiol formation have been reported in human breast tumor samples 
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VI. Phytochemicals and cancer prevention 
Development of cancer is a multi-step process that can be arbitrarily subdivided 
into initiation, promotion and progression steps that are required in transforming a 
normal cell into a neoplastic tumor cell. Naturally occurring anticarcinogenie 
compounds can play an important role in cancer prevention by inhibiting one or more 
of the important steps in tumor cell development (Forum Symposium on Mechanisms 
of Action of Naturally Occurring Anticarcinogens, 1998). Also certain plant-derived 
compounds may offer protection against the formation and action of mutagenic and 
carcinogenic metabolites by one or more of the following mechanisms: (a), inhibition 
of metabolic activation; (b). preventing the interaction of reactive metabolites with 
cellular DNA; (c). enhancement of the detoxification of reactive metabolites; (d). 
suppression of mechanisms of tumor progression (Teel & Huynh’ 1998). 
Flavonoids, which are structurally similar to estrogens, are able to bind to the 
estrogen receptor and possess estrogenic or antiestrogenic activities (Le Bail et al.， 
1998). They comprise different chemical classes such as flavones, flavanols, 
flavanones, isoflavanones and chalcones (Miranda et al., 1999) (Figure 1.9). 
Flavonoids occur in virtually all green plants, with the exception of algae, and they 
can be found in all parts of the plant: leaves, flowers, fruits, berries, roots, bark, resins, 
and waxes. Humans are exposed to flavonoids through their diets. Fruits, vegetables, 
tea, and wine are rich sources of flavonoids (Stevens et al, 1998), and they are also 
known to affect the activity of enzymes that are involved in the metabolism of 
xenobiotics like drugs and (pro)carcinogens. The ultimate carcinogen has the ability 
to form adducts with DNA. Dietary compounds that inhibit the activity of cytochrome 
P450 enzymes may help terminating metabolic steps that lead to formation of 
carcinogens (Stevens et al.，1998). 
Some flavonoids induce Phase 11 enzymes both in vivo and in vitro. The dietary 
chemopreventive agents may inhibit carcinogen activation by controlling the balance 
between carcinogen-activating Phase I enzymes (such as cytochrome P4501) and 
Phase n detoxifying enzymes (such as UGTs). Factors which suppress Phase I 
enzymes or induce Phase n enzymes are likely to have a protective role against 
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Figure 1.9—Chemical structures of flavonoids and their five subtypes. 
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vn. Outline of this study 
Many phytochemicals have long been known for their anticancer effects, but the 
mechanisms are still unclear. In order to investigate the chemopreventive effects of 
these natural compounds and effects related to their chemical structures, a series of 
cell culture-based studies were carried out. 
Project One: Phytochemicals antagonize XRE transactivation and display 
protective effects on DMBA toxicity. 
Since CYPlAl/ lBl catalyzed procarcinogens into carcinogens leading to DNA 
damage, the inhibitory effects of chalcones, monoterpenes and lycopene on induced 
CYPl Al / lBl enzymes and the mechanisms were investigated. 
Project Two: Regulation of phytochemicals on UDP-glucuronosyltransferases 
(UGTs) enzyme activities and gene expressions 
UGTs are Phase n enzymes, which could eliminate carcinogens from cells, and 
their activities could also be induced by DMBA. Through checking the microsomes 
extracted from phytochemicals-treated MCF-7 or HepG2 cancer cells, the issue 
whether these phytochemicals could increase UGT enzyme activities was addressed. 
Semi-quantitative RT-PCR assays were employed to investigate their effects on 
UGTlAl gene expression. 
Project Three: Effects of phytochemicals on CYPl enzyme-mediated estradiol 
hydroxylation pathways 
MCF-7, one of the ER-positive breast cancer cell lines, is highly responsive to 
estrogen treatment. A HPLC method was developed to separate the estradiol 
metabolites in this model. In order to increase the sensitivity, the substrate 17 3 
-estradiol was [^H] radiolabeled, so the hydroxyestradiols could be detected by a 
radioactive detector. The quantities of hydroxyestradiol inferred the effects of 
phytochemicals on estradiol-hydroxylase activity. 
One crucial anticancer effect depends on the protection of DNA lesions; the 
phytochemical, which can inhibit CYPl enzymes and increase the UGT enzyme 
activities offers the most protection. 
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CHAPTER 2 MATERIALS AND METHODS 
L Chemicals 
All chemicals including hydroxychalcones, ethoxyresorufin, DMBA and the 
carrier solvent DMSO were purchased from Sigma Chemicals (St Louis, MO, USA). 
[G-^H]7,12-Dimethylbenz[a]anthracene was obtained from Amersham Pharmacia 
Biotech UK Limited (Buckinghamshire, UK). p-Glucuronidase/Arylsulfatase was 
brought from Roche Molecular Biochemicals (Mannheim, Germany). All other 
chemicals, if not stated, were acquired from Sigma Chemicals. 
11. Cell culture and treatments 
1. Maintenance of cells 
MCF-7 cells (American Tissue Culture Collection, Rockville, USA) were grown 
in DMEM media (GibcoBRL, NY, USA) supplemented with 50 units/ml penicillin 
-streptomycin (GibcoBRL) and 10% v/v fetal bovine serum (Invitrogen Life 
Technology, Rockville, MD, USA) in a 5% CO2 humidified incubator (NuAire, 
Plymouth, MN, USA) at 37�C. When cells reached about 80% confluence, the 
medium was removed and the cells were trypsinized with 2 ml trypsin-EDTA for 5 
min. The cell suspension was transferred to a 15 ml centrifuge tube containing 10 ml 
PBS and centrifiiged at 1,000 rpm at room temperature for 5 min. The cell pellet was 
resuspended with fresh medium and cultured in new flasks. 
HepG2 cells (A.T.C.C.) were grown in RPMI - 1640 phenol red free media 
(Sigma Chemicals) supplemented with 50 units/ml Penicillin -Streptomycin 
(GibcoBRL) and 10% v/v fetal bovine serum (Invitrogen Life Technology) in a 
humidified incubator at 37°C, in 5% CO2. When cells reached about 80% confluence, 
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the medium was removed and the cells were trypsinized with 3 ml trypsin-EDTA for 
10 min and the following steps are the same as MCF-7 cells (Chan, 2002). 
2. Preparation of cell stock 
Semi-confluent cells in 75 cm^ flasks were washed with PBS and trypsinized as 
( 
described above. After centriftigation, the cell pellet was suspended in 450 ijd of 
DMEM/RPMI supplemented with 10% v/v FBS and transferred into a 2-ml 
cryo-freezing tube containing 450 \Jd of FBS and 100 |il of DMSO. The tube was put 
in an isopropanol-filled container (Nalgene, USA) and stored in a -80°C freezer, so 
the cell stock was frozen at a constant rate of about 1°C /min. The cell stocks were 
stored at -80�C or liquid nitrogen after 1 day (Chan, 2002). 
3. Cell recovery from liquid nitrogen stock 
The cell stock was taken out from -80°C freezer or liquid nitrogen tank and 
thawed immediately in a 3TC water bath. To remove the DMSO, the cell stock was 
diluted into 10 m] of DMEM/RPMI with 10% v/v FBS. The cell suspension was 
centrifuged as described above and the supernatant was discarded. The cell pellet was 
then suspended in 10 ml of DMEM/RPMI with 10% v/v FBS, plated on a 75 cm^ 
culture flask and incubated as above. The medium was changed one day after 
recovery of the cells (Chan, 2002). 
4. Measurement of cell viability 
Cell viability was assessed by 3-(4,5 dimethylthiazol-2-yl)-2,5-diphenyl 
tetrazolium bromide (MTT) straining as described by Mosmann (1983). Briefly, 
MCF-7 cells were plated in 96-well plates at lO^ cells per well, and 1 jiM DMBA and 
various concentrations of phytochemicals were administered for 24 h. At the end of 
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the treatment, 50 |il of 1 mg/ml MTT was added and the cells were incubated at 37°C 
for 3 h. Then 100 |il of DMSO was added and the plate was allowed to stand at room 
temperature for 30 min. Cell viability was determined by the absorbance at 600nm. 
5. Preparation of cell lysates (NP-40 cell lysis buffer) 
I 
To harvest the cells, the medium was discarded and the cells were washed once 
with PBS. The cells were scraped off from the plate and resuspended in the residual 
PBS. The suspension was transferred into a 1.5 ml Eppendorf tube. Another 1 ml of 
PBS was added to the plate and the residual cells were scraped off. The suspension 
was again transferred to the same Eppendorf tube and centrifuged at 13,000 ipm in a 
desktop centrifuge for 30 s; the supernatant was discarded. The cell pellet was 
resuspended with three pellet-volumes of cell lysis buffer supplemented with protease 
inhibitors mixture and incubated on ice for 30 min. To get rid of the cell debris, the 
resuspension was centrifuged at 13,000 rpm in a desktop centrifuge for 30 min at 4°C. 
The supernatant was saved and transferred to a new Eppendorf tube. The protein 
concentration of the lysate was measured as described above (Chan, 2002). 
6. XRE-luciferase gene reporter assay 
a. Transient transfection of cell using lipofectamine PLUS reagent 
MCF-7 cells were seeded at 10^  cells/well in 24-well plates. After 24 h, the cells 
were transiently transfected with 4.0 jig of the XRE reporter plasmid and 1.0 |ig of 
renilla luciferase control vector pRL (Promega, Madison, WI, USA) in 
LipofectAmine PLUS (Invitrogen Life Technologies). After 16 h, the transfection 
medium was removed and 1ml of fresh medium was added to each well. Cells were 
then treated with 1 |iM DMBA and various concentrations of phytochemicals for 24 h. 




b. Dual Luciferase Assay 
Dual Luciferase assays were preformed according to the manual (Promega). 20 
|il cell lysate was mixed with 50 pJ of reaction buffer supplemented with firefly 
luciferase substrate. The luciferase bioluminescence was measured by using a 
I 
FLUOstar Galaxy plate reader (BMG Labtechnologies, Offenburg, Germany). The 
XRE trans activation activities represented by firefly luciferase light units were then 
normalized with that of renilla luciferase (Chan et al., 2002). 
III. Enzyme Activities 
1. Isolation of microsomes 
This method had been described before (Ciolino & Yeh，1999b). MCF-7 cells 
were treated with 1 [M of DMBA to induce CYPlAl & IBl activities. After 24 h 
these cells were trypsinized, centrifuged at 1,000 rpm for 5 min at 4°C. The cells were 
then suspended in storage buffer (10 mM Tris-HCl, 0.25 M sucrose, pH 7.5，with 100 
lig/ml phenylmethylsulphonylfluoride, 300 |ig/ml EDTA, 0.5 |a,g/ml leupeptin, 0.5 
|ig/ml aprotinin, 0.7 |ig/ml pepstatin A), and sonicated on ice for 30 s. The lysate was 
centrifuged at 5,000 rpm for 15 min, and the supernatant was collected and 
centrifuged again at 45,000 rpm for 30 min at 4°C. The microsomal pellet was 
resuspended in the storage buffer, aliquoted and stored at -80�C. The concentration of 
microsomal protein was determined by a Bradford-based BioRad protein assay as 
described above. 
2. EROD activities in intact cells 
The assay method was performed as previously described (Ciolino & Yeh， 
1999a). In brief, MCF-7 cells in 96-well plates were treated with 1 i^M DMBA and 
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various concentrations of phytocheraicals. The medium was then removed and the 
cells were washed twice by 100 |il PBS. Ethoxyresorufin-O-deethylase (EROD) 
activities, which are indicatives of CYPlAl and CYPIBI enzyme activities, were 
then carried out. 100 |aJ of 5 |iM ethoxyresorufin (ER) in PBS with 1.5 mM 
salicyclamide was added to each well, and incubated at 37°C for 15 rain. The reaction 
was stopped by 100 yd of ice-cold methanol, and the resorufin generated was 
measured by a FLUOstar Galaxy microplate reader (BMG Labtechnologies) with an 
excitation of 544 nm and emission at 590 nm. The activities were quantitated against 
resorufin standards. 
3. EROD inhibition assay 
A reaction mixture containing 1.6 pmol human recombinant CYPlAl or 2 pmol 
CYPIBI was incubated in 100 \\1 PBS, pH 7.2 with 5 _ ethoxyresorufin (ER) and 
phytochemicals in different concentrations. The reaction was initiated by 500 jiM 
NADPH, and stopped by 100 [i\ ice-cold methanol. After 15 min of incubation, the 
fluorescence was measured as described above (Ciolino & Yeh.’ 1999a). 
To determine the kinetics of CYPl enzyme inhibition, 280 jil of 0.1 |xM�1.6 joM 
ER were prepared in the presence of various concentrations of phytochemicals. Three 
80 fjJ of aliquots of each (yielding final concentration of 0.1 | iM�1.6 |xM) was placed 
in a 96-well plate and the reaction was initiated by the addition of 20 yd 2.5 mM 
NADPH (final concentration 500 jxM) and 2 pmol human recombinant CYPlAl or 
2.5 pmol CYPIBI per well. After 15 min, 100 |il of ice cold methanol was added and 
the reaction was assayed as described above. 
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ly. Manipulation of Nuclear Acid 
1. Preparation of transfected DNA (Chan, 2002) 
a. Separation and purification of DNA from agarose gel 
Different percentages of agarose gels (typically 1.0%~2.0%, w/v) were prepared 
with TAB buffer containing 0.4 |ig/ml of ethidium bromide. DNA samples were 
I 
loaded on the gel immersed in TAE buffer and separated at 90V~110 V for 45 min; 1 
kb marker or 100 bp marker was used as size control. The objective bands were cut 
from the gel and purified with the Rapid Gel Extraction Systems (Invitrogen Life 
Technologies). 30 [jd of Gel Solubility Buffer (LI) was added for every 10 mg of gel 
in a 1.5 ml microtube at 50°C to completely dissolve. The mixture was then transfer to 
a cartridge on the top of a 2 ml wash tube and centrifuged at 13,000 rpm in a desktop 
centrifuge for 1 rain. The solution in the collection tube was discarded; 0.7 ml Wash 
Buffer was added to the cartridge, which was then incubated at room temperature for 
3 min and centrifuged as above. The cartridge-collection tube assembly was 
centrifuged for another 1 min to remove the residual wash buffer. The DNA was 
eluted with 40 |il of MQ water and collected by centrifugation into a new clean 
microtube. The eluted DNA was stored at -20°C or used immediately. 
b. Restriction digestion 
Restriction digestion was carried out to prepare DNA inserts for subcloning or 
for confirmation of transformation products. In order to prepare DNA inserts, 5 jug of 
plasmid DNA was applied and the total reaction volume was 50 |il. For 
transformation products detection, 1 jug plasmid DNA was used and the total reaction 
volume was 15 |li1. All restriction enzymes and the respective lOx buffers were 
products from New England BioLabs. Plasmid DNA was mixed with restriction 
enzymes (1 or 0.1 unit each) and lOX buffers (5 or 1.5 |il); then the volume was 
brought to 50 |il or 15 |il by MQ water. All the reactions were incubated in a 37°C 
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water bath for 3 h unless instructed otherwise by the manufacturer. 
c. Ligation of DNA fragments 
The T4 ligase (400 unit/ |al) and lOx T4 ligase buffer applied in all ligation 
reactions were products from NEB unless specially stated. The DNA insert and vector 
were mixed at a 3:1 concentration ratio (determined by resolving them on agarose gel), 
4 
with 2 |il of lOx T4 ligase buffer and 400 units of T4 ligase (one unit being defined as 
the amount of enzyme required to give 50% ligation of Hind EI fragments of Lambda 
DNA in 30 min at 14°C in 20 }il and a 5'- DNA termini concentration of 0.12 |iM). 
The volume was brought up to 20 \x\ with MQ water. The reaction was incubated at 
room temperature for 2 h or at 14°C for 16 h. Then the ligation product was stored at 
-20°C or used immediately for transformation. 
d. Transformation ofDH5a 
Total ligation mixture or 1 |ig of plasmid DNA was transferred into a 1.5 ml 
microtube containing 200 |il of competent DH5a cells and kept on ice for 30 min. 
Then cells were placed into 42° C water bath for 1.5 min for heat shock and chilled on 
ice 3 min for cold shock. The transformation mixture was mixed with 1 ml of LB 
medium and incubated at 37°C in a shaker for 30 min. The mixture was then 
centrifiiged at 1,000 rpm in a desktop centrifuge for 5 s, and 900 |il of the supernatant 
was discarded. The pellet was resuspended in the residual medium and plated on 
l b amp plate and incubated at 37° C overnight. Transformation products that grew on 
plate wkh single colonies were transferred into 2 ml of LB咖p medium with toothpicks 
and shaked overnight at 37°C. The cultures were screened by PGR with appropriate 
primers and analyzed with agarose gel electrophoresis. Transformation products that 
scored positive with the PGR screening were further analyzed by restriction digest 
after mini-prep. One of the transfonnants was then inoculated into 200 or 500 ml of 
medium and grew with shaking at 37°C overnight. Large-scale plasmid 
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isolation (maxi- or giga-prep) was then performed. 
e. Small scale plasmid purification from DH5a (mini prep) 
A single colony of transformed DH5a on a LB'^^ plate was incubated into 2 ml 
LB咖P medium shaking overnight at 37°C. Then the culture was transferred into a 
microtube and pelleted; discarding the supernatant. Plasmids were purified by a rapid 
miniprep system (Invitrogen Life Technologies). 100 |li1 of PI buffer was added into . 
the microtube, followed by vortexing. The suspension was then mixed with 100 |il of 
P2 and incubated at room temperature for 10 min to lyse the cells. P3 (100 |il) was 
then added and the lysate was incubated at 4°C for 5 min to neutralize the lysates. The 
lysate mixture was centrifuged at 4°C and 13,000 rpm in a desktop centrifuge for 10 
min. The supernatant was then transferred to a new microtube and the plasmid DNA 
was purified by resins inside a column. 
f . Large scale plasmid isolation from DH5a (maxi-prep) 
A rapid maxiprep system (Invitrogen Life Technologies) was used to prepare 
plasmid DNA at large scale. An overnight culture of transformed DH5a (500 ml of 
LB'^P) was transferred into a 500 ml conical tube and centrifuged at 6,000 g for 10 
minutes. The supernatant was discarded and the pellet was resuspended in 10 ml PI 
solution. Then 10 ml P2 solution was applied to the resuspended culture and 
incubated at room temperature for 5 minutes. In order to neutralize the lysate, 10 ml 
of P3 solution was pipetted into the lysate, followed by incubation on ice for 10 
minutes. The cell debris was separated from the plasmid DNA by centrifogation in a 
30 ml centrifuge tube at 13,000 rpm in a desktop centrifuge for 30 minutes. To further 
remove the debris, the supernatant containing the plasmid DNA was transferred to a 
new 30 ml centrifuge tube and centrifuged for another 30 minutes. QBT solution was 
added to the maxi-prep column to activate the resin at the bottom of the column. After 
all the QBT had gone through the column, the cell lysate was poured into the column 
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until all of the lysate had eluted out. To wash the resin, one column volume of QC 
solution was added to the column twice. To elute the DNA from the resin, the column 
was assembled to a 15 ml centrifuge tube containing 15 ml of 100% isopropanol; then 
15 ml of QF solution was added to the column. The fluant was mixed with the 
isopropanol by inversion. To precipitate the DNA, the solution was centrifuged at 
10,000 g for 45 minutes; then the supernatant was discarded and the pellet dried at 
room temperature. Finally 400 |li1 MQ water was added to the tube to resuspend the 
pellet. 
g. Construction of XRE activated luciferase reporter gene 
A fragment with five XRE elements from rat CYPlAl 5'-flanking region was 
amplified using primers (XRE FOR and XRE REV) specific for rat genomic DNA as 
described by Backlund (1997). No other response elements were identified in this 
fragment. The PGR product was digested with Smal and BamHI and subcloned into a 
firefly luciferase reporter vector pTA—Luc (Clontech, Palo Alto, CA, USA). 
2. Measurement of DMBA-DNA adduct formation 
This assay was performed as previously described (Ciolino & Yeh, 1999a). 
MCF-7 cells were plated into 6-well plates at 5x10^ cells per well and allowed to be 
attached for 24 h. Then 0.1 \ig / ml [^H]-DMBA (Amersham, Arlington Height, IL, 
USA) was administered with or without phytochemicals. After 16 h, cells were 
washed twice by cold phosphate-buffered saline (PBS), trypsinized and pelleted. 
Nuclei were separated by incubating 10 min on ice in cell membrane lysis buffer (10 
mM Tris-HCl, 320 mM sucrose, 5mM MgClz and 1 % Triton X-100, pH7.5). Then 
nuclei were collected by centrifugation at 5,000 rpm for 10 min at 4°C. After that, 
lysed the nuclei by 400 |il nuclear lysis buffer (1 % sodium dodecyl sulphate (SDS) in 
0.5 M Tris. 20 mM EDTA and 10 mM NaCl, pH 9.0), followed by the treatment of 20 
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|jJ 10 mg / ml Proteinase K for 2 h at 48°C. Cold down the samples and the residual 
protein was salted out by adding 150 |jJ saturated NaCl. The products were then 
subjected to centrifugation at 13,000 rpm for 30 min at 4�C. Genomic DNA was 
isolated from supernatant by ethanol precipitation, and redissolved in MQ water. 
Determined the quantity and purity of extracted DNA by absorbance readings at 260 
I 
nm and 280 nm. DNA samples attained a 260nm/280nm ratio higher than 1.9 were 
selected for scintillation counting. 
3. Semi-quantitative RT-PCR Assay 
‘ a. Isolation ofRNA using TRIzol® Reagent (Invitrogen Life Technology) 
Total RNA was isolated from cells growing in 6-well Costar plates in triplicates 
by Trizol Reagent as described by the manufacturers (Invitrogen Life Technology). 
Washed cells twice with cold PBS. 1 ml TRIzol reagent was added in each well and 
aspirated several times to lyse the cells. The homogenous sample was incubated at 
room temperature for 5 min and transferred to a microtube, adding 0.2 ml chloroform. 
Then mixed the samples vigorously by shaking 15 s to keep at room temperature, for 
3 min. The sample was then subjected to a centrifugation at 12,000 g for 15 min at 
4°C. Afterward, the upper aqueous layer was transferred to another new microtube 
containing 0.5 ml isopropanol. After incubated at room temperature for another 10 
min, centriftiged at 12,000 g for 10 min at 4�C. Discarded the supernatant and the 
RNA pellet was mixed with 1 ml 75 % ethanol. Then re-pelleted and air-dried. Added 
50 [i\ DEPC-treated water to redissolve the RNA pellet, and stored at -80�C. 
Determined the quantity and purity of RNA by absorbance readings at 260nm and 
280nm. The exact quantities were calculated by the formula: OD260 * 40 mg nil'^ = 
Quantity of RNA (mg ml"^). RNA isolated by this method exhibited a 260/280 ratio 




A reverse transcription-polymerase chain reaction (RT-PCR) assay was carried 
out to quantitate the mRNA level. 5 |ig total RNA was applied for cDNA synthesis, 
and the final volume was diluted to 20 |il. Primer sequences of CYPlAl, CYPIBI, 
UGTl A1 and (3-actin, as published formerly (Dohr et al., 1995 & Guillemette et al., 
2000) and a Perkin Elmer Therraocycler (GeneAmp PGR System 2400, Norwalk, CT, 
USA) was utilized to amplify the target cDNAs separately after the first strand 
reaction. All PGR reactions consisted of 0.2 mmol/L dNTP, 2 cDNA, 0.2 |LimoI/L 
of each primer, IxPCR buffer and 1 U Taq polymerase and ddHzO to total volume 25 
|il. The conditions were: 
3-actin: 94�C 5 min; 
[94�C 45 s, 6 5 � C 1 min, 7 2 � C 1 min] (19 cycles); 
72°C7min. 
CYPlAl: 94�C5min; 
[94°C 45 s，60°C 45s，72°C 45 s] (25cycles); 
72 °C 7 min. 
CYPIBI: 94°C 5 min; 
[94°C 45 s, 63 °C 45 s , 72 45 s] (24 cycles); 
72 °C 7 min. 
UGTlAl: 94�C 5 min; 
[94�C 1 min, 6 3 � C 1 min, 72 1.5 min] (28 cycles); 
72 oc 10 min 
The PCR products were separated on an 1.5% agarose gel, stained with ethidium 
bromide, and photographed. A scanner equipped with Scion Image software (Scion 
Corporation, Frederick, MD, U.S.A.) was used to compare the optical density of the 
amplified fragments. The linearity of signals was verified in separate experiments. 
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V. Phase II enzyme-UDP-glucuronosyItransferase (UGT) activity assay 
The assay was carried out as previous described (Neumann & Zaiinoni, 1990). 0.2 
mg microsomes extracted from MCF-7 or HepG2 cell was applied to each reaction. 
After adding 9 |il Emulgen 911 (Kao Corporation, Tokyo, Japan), the mixture was 
continuously stirred at 4 � C for 30 min to activate UGT. Then 100 |jJ 1 M NaHzPCU 
(PH 7.1), 16 |il 25 mM UDPGA, 50 5 mM p-nitrophenol were added and total 
volume was adjusted to 400 jjJ by water. The mixture was incubated at 37 °C in the 
dark for 0 min, 5min, lOmin, 20 min separately. 100 \jd product was incubated in 1.5 
ml 0.25 M KOH and the absorbance reading at 400 nm was obtained. Then a plot with 
X-axis of the incubation time (min) and Y-axis encompassing the absorbance reading 
at 400 nm was drawn. The rate of reaction was Slope / £ (M min'^). (The molar 
extinction coefficient(e) of p-nitrophenol at 400 nm was 1840 M'^  cm]). Finally the 
UGT specific activity was calculated by the formula: Slope / 1840 * 1.05 * 10^ / 0.2 
(nmol min-i mg'^). 
Effect of DMBA on specific activity of UGT in 
HepG2 cells 
18 -I NS 
16 - T 
^ M 14 -
1 1 12-
.曰 T 
| l - — _ 為 差 r _ _ _ 
Control 0 (DMBA) 
Figure 2.1—Effect of DMBA on UGT specific activity in HepG2 cells. 
DMBA had no significant effect on UGT specific activity in HepG2 cells. 
Values are means 土SE, n=3. 
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VI. HPLC for estradio l-hydroxylation analysis 
1. HPLC condition for hydroxyestradiol separation and measurement 
HPLC instrument: Hewlett Packard 1100 (HP, Waldbronn, Germany) 
G1311A: QuatPump; G1313A: ALS; 
G1315A: DAD; G1322A: Degasser 
t 
Software: HP Chemstation for LC (Rev.: A.04.02) 
Column: C18, 250x4.6 mm, 5 |im (SUPELCO, Bellefonte USA) 
Mobile phase: 58.5% H2O; 20% methanol; 20% acetonitrile; 
1.5% acetic acid (filtered and degassed) 
Flow rate: 1ml/min 
Column temperature: 25 
Detection wavelength: 230nm 
Retention time: (Figure 2.2) 
16(x-Hydroxyestracliol (16a-OHE2)~6.7 min; 
4-Hyclroxyestradiol (4-OHE2)—16.6 min; 
2-Hydroxyestradiol (2-OHE2)—20.2 min; 
Estradiol (E2)—33.3 min 
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Figure 2.2—HPLC standard chromatogram. 
2. Determination of microsomal estradiol hydroxylase activity 
The method was performed as previously described (Spink et al.，1992). Each 
250 jil reaction system contained 100 |il reaction buffer (5 mM MgCh, 2 noM 
ascorbic acid, 100 mM NaHzPO*, PH 7.4)，2.5 |il phytochemicals with different 
concentrations, 2.5 |il 10 |j,M estradiol (or 50 nM with [^H] labeled ) as substrate, 20 
pj 0.5 [ lMhuman recombinant CYPlAl / lBl microsomes (GENTEST, Wobum, MA, 
USA). The mixture was pre-incubated at 37 for 5 min, then 25 |il 14 mM 
P-NADPH was added to trigger the reaction at 37 for another 15 min. 0.5 ml 30 
mM ice cold ascorbic acid was added to terminate the reaction. The hydroxylation 
product was extracted by ethyl acetate twice, then was dried in a stream of nitrogen 
gas. The dried reaction was redissolved in methanol to do HPLC assay as above. 
3. Assay of estradiol metabolism in MCF-7 cells 
The assay was carried out as previously described (Spink et al., 1994). MCF-7 
cells were seeded in 6 well plates. After 1 day incubation at 37 the cells were 
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treated with DMBA and phytochemicals for another day. Then the old medium was 
replaced by a new medium containing 10 |j.M estradiol (with or without [^H] labeled). 
8 h later the medium was recovered and treated with p-glucuroiiidase (3,000 units / ml, 
PH 5.0) for another 18 h. Cells were harvested and washed by PBS (PH 7.4). The 
protein content of the cell lysate was determined by the method described (Kennedy 
& Jones，1994). The estradiol metabolies in the medium were extracted by ethyl 
acetate twice and the following steps were same as the microsomal assay described 
above. 
VIL Statistical Analysis 
A Prism® 3.0 software package (GraphPad Software, Inc., CA, U.S.A) was 
utilized for statistical analysis. The results, whenever applicable, were analyzed by 
One-way ANOVA followed by Bonferroni's Multiple Comparison Test if significant 
differences (p<0.05) were observed. T-test was also performed to compare the cell 




CHAPTER 3 CHALCONES ANTAGONIZE 
DMBA-INDUCED CARCINOGENESIS BY 
MODULATION OF CYPlAl/lBl AND UGT 
ACTIVITIES 
Part One Introduction 
Chalcones or 1,3-cliaryl-2-propen-l-ones (Dimmock et al” 1999) are the 
intermediate precursors for all flavonoid compounds and have flavonoid-like 
structures lacking a heterocyclic C ring (Le Bail et al.，2001). In order to produce 
chalcones, fusion of three acetate C2 units with coumaric acid yields a chalcone-type 
flavonoid. The reaction is catalyzed by the enzyme chalcone synthase (CHS) found in 
hops, plants (Jez et al., 2000), and illuminated buckwheat (Hrazdina et al., 1986). 
Then the chalcone-type flavonoid is hydrolysed into chalcone (Jez et al.，2000) 
(Figure 3.1 & 3.2). Chalcones are abundantly present in nature from ferns to higher 
plants (Anto et al., 1995), and the vast majority of naturally occurring chalcones are 
polyhydroxylated (De Vincenzo et al, 2000). Hydroxychalcones can also be 




\ y C H S ^ 
攀释 
Figure 3.1Chalcone synthase (CHS) 3D structure. Red: the catalytic cysteine; 
Green: the three positions that convert CHS into 2-PS; Blue: the substitution that dose 
not affect product formation (Jez et al.，2000). 
4N-terminal • ^^^^^^^ , C-termlnal (B) 
幽 
A' C“fl"Wliy S Uolotiy 
Figure 3.2Overall structure of CHS. Each monomer is colored blue and gold, respectively, 
in this ribbon diagram. The N- and C-temini for each monomer are indicated. The catalytic 
cysteine is shown in relaton to the acetoacetyl-CoA molecule. Also, the methionine that forms 
part of the back wall of the initiation/elongation cavity is shown (Jez et al., 2000). 
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Chalcones have various documented bio activities, including cytotoxic, anticancer, 
cheraopreventative and mutagenic properties; antibacterial, antifungal, antiviral, 
antiprotozoal and insecticidal properties; enzyme inhibiting properties; antihistaminic 
and antiinflammatory properties (Dimmock et al., 1999 & De Vincenzo et al., 2000). 
They can also pass cell membranes and interact with receptors and enzymes, such as 
the CYP enzymes (Le Bail et al, 2001). 
Chalcones have been found to inhibit the proliferation of various kinds of human 
malignant tumour cells (Miranda et al., 1999). Methyl and hydroxy substituted 
chalcones are cytotoxic in vitro whereas only hydroxy substituted chalcones could 
reduce ascites tumour in animals (Anto et al., 1995). The first step of the 
transformation of a normal cell to a cancer cell begins with the activation of the 
procarcinogen by CYP enzymes (Ciolino & Yeh, 1999b). Therefore the cancer 
prevention effects of chalcones might originate from its CYP enzyme inhibition. 
Chalcones' chemopreventive property may be attributed to their ability to induce 
the Phase II detoxifying enzymes, quinone reductase and glutathione ^-transferase 
(Mesia-Vela et al., 2002). In the chalcone structure, the a,(3-unsaturated carbonyl 
moiety is chemically reactive, and compounds containing this structural arrangement 
have been shown to induce activities of Phase n enzymes (Wattenberg, 1995). 
Increased activity of Phase II enzymes can stop the initiation of chemical 
carcinogenesis (Makita et al, 1996). As the ultimate outcome of carcinogenicity is 
dependent on a balance of bioactivation and detoxification enzymes (Mesia-Vela et al., 





2, -Hydroxy chalcone 
2-Hydroxychalcone 4-Hydroxychalcone 
4，2,,4,-Trihydroxychalcone 3,4,2,,4,-Tetrahydroxychalcone (Butein) 
(Isoliquirtigenin) 
Figure 3.3Chemical structures of chalcone and 5 hydroxychalcones, 
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Part Two Results 
Section One Chalcones antagonize DMBA carcinogenesis bv 
inhibiting CYPlAl and CYPIBI activities 
I . Chalcones inhibited DMBA-induced EROD activities in MCF-7 cells 
The significance of both CYPlAl & IBl enzymes has been implicated in 
chemical carcinogenesis in recent researches. Because CYPlAl and IBl enzymes 
specifically catalyze ethoxyresorufin into resorufin, the fluorescent signal can be 
quantitatively detected by a flurometer. The EROD activity is the indicative of 
CYPlAl and CYPIBI enzyme activities. 
In order to measure the EROD activity, a resorufin fluorescence density standard 
curve was constructed (Figure 3.4). 
賓燃巡fiifififsfffiiftfi雄燃應腳i懇粥ff應應娜裕腦應fi腿腿删邏麵麵娜體懸雜應娜fffff懸mp 
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Figure 3 . 4 T h e resorufin fluorescence density standard. 
EROD activity in intact MCF-7 cells that had been exposed to 1 pM DMBA in 
the presence of chalcones for 24 h was measured. DMBA-induced EROD activities in 
cell cultures were reduced by the 5 chalcones tested except for 2-hydroxychalcone in 
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Figure 3.5_Diverse effects of chalcones on DMBA-induced EROD activities. 
MCF-7 cells were seeded in 96-well culture plates and treated with 1 |iM DMBA 
and various concentrations of chalcones: chalcone (A), 2‘-hydroxychalcone (B), 
2-hydroxychalcone (C), 4-hydroxychalcone (D), 4,2' ,4'-tiihydroxychalcone (E) and 
butein (F) . After 24 h of treatment, cells were assayed for EROD activity as 
described. The values are means 土SE，n=8. All data are significantly different from the 
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n . Inhibition of chalcones on microsomal CYPlAl & IBl enzyme activities 
A 
110 n a —chaJcone 
2 irtrt i ^ T a —2'-hydro)ychalcone 
"S l ^ A 丁 A 2-hydro5ychalcone 
9Q - a J 4-hydto)y chalcone 
a A^^^ „ —4,2',4'-trihydroxy chalcone 
I 20 -
-z 10- ^ 
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• _ ——•~ 2'-hydro?ychalcone 
g 1 0 0 * —A~ 2-hydro\ychalcone 
扫 QH ^ B 4-hydro?y chalcone 
O • l \ —4’2’,4'-trihydn>??y^ chalcone 
^ 80 +butein 
I 
(J H 1 1 1 I T 丨 1 1 — 1 I 
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[Chalcones] |iM 
Figure 3.6~Effects of chalcones on human recombinant CYPlAl (A) & 
CYPIBI(B) EROD activities. 
500 nM ethoxyresorufin was added to each reaction. Their activities in human 
recombinant CYPlAl/lBl microsomes were measured in the presence of 
indicated concentrations of chalcones. EROD activities in all chalcones-treated 
samples were statistically different from the controls {P < 0.05). Values are means 
士SE, n=3. Means without same letters differ (F<0.05). 
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As chalcones were shown to inhibit DMBA-induced CYPl enzymes in intact 
MCF-7 cells. Then their inhibitory patterns on CYPlAl and CYPIBI enzyme 
activities were further investigated. The results of microsomal EROD assay indicated 
that all of the six chalcones significantly reduced CYPIBI enzyme activity with IC50S 
around 0.5 |iM, but they modestly inhibited CYPlAl enzyme activity with IC50S 
ranging from 2 to 10 |a.M (Figure 3.6). , 
Kinetic analysis of chalcones on CYPlAl and CYPIBI activities 
The kinetic analyses with human recombinant CYPlAl and CYPIBI 
microsomes in the presence of 100-1600 nM ethoxyresorufin and various 
concentrations of chalcones were carried out as described in Material and Methods. 
Lineweaver-Burk plot were generated by linear regression of the reciprocal data. Inset, 
replot of the slopes from the Lineweaver-Burk plot derived the value of Ki. Results 
showed that chalcones competitively or noncompetilively inhibked CYPlAl / lBl 
enzyme activities with Ki values summarized in table 3.1. Values shown here are 
mean ±SE，n=3 (Figure 3.7*). 
(*: A~chalcone; B—2'-hydroxychalcone; C—2-hydroxychalcone; 
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Figure 3.7A—Lineweaver-Burk plot of chalcone on CYPlAl (3.7A-1) & CYPIBI 
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Figure 3.7B一Lineweaver-Burk plot of 2'-hydroxychalcone on CYPlAl 
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Figure 3.7C—Lineweaver-Burk plot of 2-hydroxychalcone on CYPlAl (3.7C-1) 







« • O^iM 
Z I 5- O 0.5^ lM ^ 
Z 5 • _ / 
a4 • — • 5|JM 
I .3. • 4- • 聊 , / / 
A i t 
[4-hydlroxydialcone] pM {S ^ ^ ^ ^ ^ ^ ^ ^ ^ 
I 梦 ‘ ‘ ‘ ^ 
沿 / ( 2 4 6 8 10 
"3 1 




1 10 j • T / 
a, o o.SfiM J X 2-1 z 
S • _ ^ X J 
藍 8 - • 5 M M 
|! ： ^ X 
^ 1 ； ； ； ； ； s 
c 。一 [4hydhxKychalcone]^ IVI 
S ' 1 1 1 1 1— 
Si (( 1 2 3 4 5 
0 
1 l/[Ethoxyresorufin] 
Figure 3.7D一Lineweaver-Burk plot of 4-hydroxychalcone on CYPlAl 







5 • OnM 
2 o 0.5jiM 
>H T luM ^ ^ 
^ 2- • 5nM 
|{ 
I _ ^ ^ ^ ^ ^ • . . . . ~ 
5 ( 2 4 6 8 10 





I 8- • OnM 
广I — Z 
- z I \ ^^ 
‘ i ， ^ ^ ^ ^ 
； 2 ； “ “ ： T " _ <) 2 4 6 8 10 
[42:，4?"<riMkT»9dricone�pIVI , l/[Ethoxyresonifin] 
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Chalcone Ki~1.41 |iM Ki~0.19|aM 
2'-Hydroxychalcone Ki~0.38 |aM Noncompetitive 
inhibition 
2-HydroxychaIcone Ki~0.12 |iM Noncompetitive 
inhibition 
4-HydroxychaIcone Ki~4.1 |iM Ki~0.14 |iM 
4,2',4'-Trihydroxychalcone No inhibition KI~0.25 |JM 
Butein No inhibition Ki~0.025 |iM 
(3，4，2,，4’-Tetrahydroxychalcone) 
Table 3.1—CYPlAl & CYPIBI enzyme kinetics results treated with chalcones. 
All six chalcones competitively or noncompetitively inhibited CYPlAl/lBl 
enzyme activities. Among them, 2-hydroxychalcone was the most potent inhibitor for 
CYPlAl with Ki~0.12 |iM. 4,2',4'-Trihydroxychalcone and butein could not inhibit 
CYPlAl activity, but butein showed the strongest inhibition on CYPIBI enzyme. 
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in. Reduction of DMBA-induced DNA adduct by chalcones 
To explore the effects of hydroxy group substituted chalcones on 
DMBA-induced D N A damage, 0.1 |ig/ml [^ H] D M B A was added to MCF-7 cells for 
16 h in the presence of hydroxychalcones. Genomic D N A was then isolated and 
subjected to scintillation counting (Figure 3.8). Among the six chalcones， 
unsubstituted chalcone (Figure 3.8A) and 2'-hydroxychalcone (Figure 3.8B) were the 
most effective compounds with a concentration-dependent inhibition. Approximately 
50% of D M B A - D N A adduct formation was suppressed at a concentration of 5 fj.M. 
4-Hydroxychalcone had an IC50 of around 10 |iM (Figure 3.8D). 2-Hydroxychalcone 
did not reduce D N A adduct formation at all concentrations (Figure 3.8C), while 
4,2',4'-trihydroxychalcone and butein could suppresse 20-30% of D M B A - D N A 
adduct formation at 10 jiM (Figure 3.8E&F). 
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Figure 3.8—Pattern of DMBA-induced DNA adduct formation in MCF-7 
cells treated with chalcones: chalcone (3.8A)，2'-hydroxychalcone (3.8B), 
2-hydroxychalcone (3.8C), 4-hydroxychalcone (D), 4,2',4'-trihydroxychalcones 
(3.8E), butein (3.8F"). Values are means 土SE，n=3. Means marked significantly 
(户<0.05) differ from control (0 |iM). 
53 
Chapter 6 
IV. Chalcones antagonized CYPlAl XRE transactivation 
Chalcones had been proven to inhibit CYPl enzymes in intact MCF-7 cells, and 
their effects could be at the level of AhR-mediated transcription. In order to 
investigate this effect, a dual-luciferase assay was carried out. MCF-7 cells were 
transfected with xenobiotic response element (XRE) fused to a luciferase reporter 
gene, and luciferase activity was subsequently measured. DMBA-induced luciferase 
4 
activity by 3~5-fold above control level (Figure 3.9). Chalcone and 
2' -hydroxychalcone showed a concentration-dependent inhibition on the induced 
luciferase activities (Figure 3.9A&B), which indicated their antagonism on 
AhR-mediated CYPlAl transactivation. 4-Hydroychalcone and butein demonstrated 
a weaker suppression than the above said chalcones (Figure 3.9D&F). 
4,2',4'-Trihydroxychalcone slightly increased the luciferase activities (Figure 3.9E) 
and 2-hydroxychalcone demonstrated a biphasic trend of activities (Figure 3.9C). 
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Figure 3.9—Different effects of chalcones on DMBA-induced CYPlAl 
XRE-driven luciferase activities. 
MCF-7 cells were transiently transfected with a luciferase reporter gene 
containing X R E and a pRL as control. Transfected cells were treated with 1 |iM 
D M B A for 24 h in the presence of various concentrations of chalcones: chalcone 
(A), 2' -hydroxychalcone (B), 2-hydroxychalcone (C), 4-hydroxychalcone (D), 
4,2' ,4'-txihydroxychalcone (E) and butein (F). Values are means ±SEM, n=3. Means 
without same letters differ (P<0.05). 55 
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V. Chalcones suppressed DMBA-induced CYPl gene expression 
A semi-quantitative RT-PCR assay was carried out to further detect the effects of 
chalcones on CYPl gene transcription. MCF-7 cells were seeded in 6-well culture 
plates and treated with 1 p M D M B A and various concentrations of chalcones for 24 h. 
Total R N A was then isolated by Trizol reagent and semi-quantitative RT-PCR assay 
was used to determine the relative CYPlAl/lBl gene expressions. D M B A induced 
CYPlAl & CYPIBI m R N A expression by about 6 and 3-fold above basal levels, 
respectively. Figure 3.10*-1 is the gel image of the ethidium bromide-stained PGR 
fragments. Figure 3.10*-2 & -3 are the optical density readings of the CYPl A J and 
CYPIBI fragments. Values are means 土S]^，n=3. Means without same letters differ 
( 户 < 0 . 0 5 ) . 
(*: A~chalcone; B—2'-hydroxychalcone; C—2-hydroxychalcone; 
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Figure 3.10A—Effect of chalcone on DMBA-induced CYPlAl & CYPIBI 
gene expressions. 
Chalcone significantly decreased DMBA-induced CYPlAl & IBl m R N A in 
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Figure 3.10B—Effect of 2'-hydroxychalcone on DMBA-induced CYPlAl & 
CYPIBI gene expressions. 
2'-Hydroxychalcone significantly decreased DMBA-induced CYPlAl & 
IBl m R N A ill a dose-dependent manner. Values are means 土SE，n=3. 
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Figure 3.10C—Effect of 2-hydroxychalcone on DMBA-induced CYPlAl & 
CYPIBI gene expressions. 
2-Hydroxychalcone increased DMBA-induced CYPlAl m R N A and decreased 
CYPIBI m R N A at the concentration of 10 |iM. Values are means 土SE，n=3. 
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Figure 3.10D—Effect of 4-hydroxychalcone on DMBA-induced CYPlAl & 
CYPIBI gene expressions. 
4-Hydroxychalcone induced a 15% increase on DMBA-induced CYPlAl 
m R N A at the concentration of 5 |iM, but a 20% decrease on CYPIBI m R N A at the 
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Figure 3.10E—Effect of 4,2',4'-trihydroxychalcone on DMBA-induced 
CYPlAl & CYPIBI gene expressions. 
4,2',4'-Trihydroxychalcone didn't reduce CYPlAl mRNA. It could at most 
reduce 70% DMBA-induced CYPIBI inRNA, but its inhibition was not 
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Figure 3.10F—Effect of butein on DMBA-induced CYPlAl & CYPIBI gene 
expressions. 
Butein slightly increased DMBA-induced CYPlAl m R N A at the 
concentration of 1-5 |a,M, but it could decrease 60% DMBA-induced CYPIBI 
m R N A at the concentration of 10 |iM. Values are means 土SE, n=3. 
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Section Two Chalcones modulate DMBA carcinogenesis bv 
regulating UGT activities 
I . Chalcones regulated UGTlAl gene expression in MCF-7 cells 
Since chalcones had been proven to inhibit Phase I enzymes such as CYPlAl & 
CYPIBI in human breast cancer MCF-7 cells, it is necessary to further investigate 
their effects on Phase n enzymes, such as UGT. A semi-quantitative RT-PCR assay 
was also carried out to detect the effects of chalcones on UGTlAl gene transcription. 
MCF-7 cells were seeded in 6-well culture plates and treated with 1 |iM D M B A and 
chalcones for 24 h. Total R N A was then isolated by Trizol reagent and 
reverse-transcribed the cDNA. A specific 402 bp fragment in UGTlAl coding 
sequence was amplified to determine the relative UGTlAl gene expression. D M B A 
induced UGTlAl m R N A expression about 3 folds above basal levels. Figure 3.11*-1 
are the gel image of the ethidium bromide-stained PCR fragments. Figure 3.11*-2 are 
the optical density readings of the 402 bp UGTlAl fragment. Values are means 土SE， 
n=3. Means without same letters differ (P<0.05). 
(*: Achalcone; B一2’-hydroxychalcone; C—2-hydroxychalcone; 
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Figure 3.11A—Effect of chalcone on DMBA-induced UGTlAl gene 
expression in MCF-7 cells. 
Chalcone significantly increased DMBA-induced UGTlAl m R N A at the 
concentration of 5 |LLM. 3-fold induction was seen at the concentration of 10 |IM. 
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Figure 3.IIB—Effect of 2'-hydroxychalcone on DMBA-induced UGTlAl gene 
expression in MCF-7 cells. 
2'-Hydroxychalcone increased DMBA-induced UGTlAl mRNA, but its effect 
was not dose-dependent. It was most effective at the concentration of 5 |JM, which 
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Figure 3.11 C—Effect of 2-hydroxychalcone on DMBA-induced UGTlAl gene 
expression in MCF-7 cells. 
2-Hydroxychalcone significantly increased DMBA-induced UGTlAl m R N A 
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Figure 3.11D—Effect of 4-hydroxychalcone on DMBA-induced UGTlAl 
gene expression in MCF-7 cells. 
4-Hydroxychalcone increased DMBA-induced UGTlAl m R N A at all 
concentrations, but its effect was not dose-dependent. Its was most effective at 
the concentration of 1 jiM, which increased nearly 3-fold of UGTl Al mRNA. 
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Figure 3.11E—Effect of 4,2',4'-trihydroxychaIcone on DMBA-induced 
UGTlAl gene expression in MCF-7 cells. 
4,2',4'-Trihydroxychalcone increased DMBA-induced UGTlAl m R N A at 1-5 
|iM, but its effect was not dose-dependent. Its was most effective at the 
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Figure 3.11F~Effect of butein on DMBA-induced UGTlAl gene expression 
in MCF-7 cells. 
Butein did not show any increase of UGTlAl mRNA, which indicated that 
it had no effect on UGTlAl gene expression. 
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n. Chalcones affected UGT enzyme activity in HepG2 cells 
Because the phase n enzymes, such as UGT, are highly expressed in liver cells, 
human liver cancer HepG2 cells were used to investigate the regulatory effects of 
chalcones on U G T enzymes. HepG2 cells were cultured in phenol-red free 
RPMI-1640 medium for 3 days, then treated with different concentrations of 
chalcones for 48 h. Microsomes were extracted as described in Materials and 
Methods, Each reaction contained 0.2 mg microsomes and p-nitrophenol as the 
substrate. The reactions were incubated at 37°C for 0 min, 5 min, 10 min, 20 min, 
then the absorbance readings at 400 nm were measured. The calculation formula was 
also described in Materials and Methods. 
Figure 3.12—Effects of chalcones on UGT specific enzyme activities of 
microsomes extracted from HepG2 cells. Values are means 土SEM，n=3. Means 
without same letters differ (P<0.05). 
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in. Chalcones regulated UGTlAl gene expression in HepG2 cells 
As chalcones had been sown to regulate UGT enzyme activity in HepG2 cells, 
their effects on UGTlAl gene expression in HepG2 cells were checked subsequently. 
A semi-quantitative RT-PCR assay was also applied as described in Materials and 
Methods. A specific 402 bp fragment in UGTlAl gene sequence was amplified to 
determine the relative UGTlAl gene expressions. D M B A induced UGTlAl m R N A 
expression in HepG2 cells was around 2 folds above basal levels. Figure 3.13*-1 are 
the gel image of the ethidium bromide-stained PGR fragments. Figure 3.13*-2 are the 
optical density readings of the 402 bp UGTlAl fragment. Values are means 土SE, n=3. 
Means without same letters differ (户<0.05). 
(*: A~chalcone; B一2'-hydroxychalcone; C—2-hydroxychalcone; 
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Figure 3.13A—Effect of chalcone on DMBA-induced UGTlAl gene expression 
in HepG2 cells. 
Chalcone increased DMBA-induced UGTlAl m R N A at 1-5 yiM, but its effect 
was not dose-dependent. It was most effective at the concentration of 1 |jM, which 
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Figure 3.13B—Effect of 2'-hydroxychalcone on DMBA-induced UGTlAl 
gene expression in HepG2 cells. 
2'-Hydroxychalcone increased DMBA-induced UGTlAl m R N A at 
concentration of 0.5 )J.M, then it decreased UGTlAl m R N A at higher 
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Figure 3.13C—Effect of 2-hydroxychalcone on DMBA-induced UGTlAl gene 
expression in HepG2 cells. 
2-Hydroxychalcone decreased the UGTlAl mRNA, especially at higher 
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Figure 3.13D—Effect of 4-hydroxychalcone on DMBA-induced UGTlAl gene 
expression in HepG2 cells. 
4-Hydroxychalcone significantly inhibited DMBA-induced UGTlAl gene 




111 M DMBA+[4,2',4'-Trihydroxychalcone] u M 
Control 0 1 5 10 
UGTlAl 
M l — 
r 
3.13E-2 
18 -1 c b’c b 
< b T T z 16 - mm T ！ 14- f f , f l fi R 
i 12- ； 丨 _ H 
0 M I I mm ？ ’ 
， 1 � - ！ ！ i i l l H 
• 8- N I III II 
” - M i |i| i 
望 4 - I I j l i i ； 1 2- M I p i h 
。I _ , • • , I i , , . 
0 0 1 5 1 0 丨 
1|JM DMBA+[4,2',4'-Trihydroxychalcone] JXM 
Figure 3.13E—Effect of 4,2',4'-trihydroxychalcone on DMBA-induced 
UGTlAl gene expression in HepG2 cells. 
4,2' ,4' -Trihydroxychalcone slightly increased UGTlAl m R N A at 
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Figure 3.13F—Effect of butein on DMBA-induced UGTlAl gene expression 
in HepG2 cells. 
Butein significantly increased DMBA-induced UGTlAl m R N A at 
concentrations above 1 |JM, but its effect was not dose-dependent. It was most 




Part Three Discussion 
I . Chalcones are potential chemopreventive agents 
Most chemical carcinogens require metabolic activation in order to induce a 
biological response. The production of reactive metabolites is largely dependent on 
primary metabolism by the CYP enzymes. Conjugating reactions, in contrast, is a 
principal, but not invariable detoxifying mechanism. The result of exposing to an 
environmental toxin in terms of acute or chronic toxicity largely depends on the 
balance between these two processes (Manson et al., 1997). The identification of 
chemoprotective activity includes the demonstration of one or more of the following 
mechanisms: (1) inhibition of the enzymes bioactivating pro mutagens and 
procarcinogens, in particular the microsomal cytochrome P4501A (CYPlA) enzymes; 
(2) induction of detoxifying enzymes; (3) antioxidative activity; (4) other effects such 
as inhibition on formation of adducts between D N A and the ultimate carcinogenic 
metabolites, anti-tumor promoting action (Machala et al., 2001). The 
anti-carcinogenic potentials of flavonoids have been credited with their 
chemopreventive activity against chemical-induced tumorigenesis, in vitro and in vivo 
modulations of Phase I and Phase II enzymatic activities and their antioxidant activity 
(Machala et al., 2001). 
It has been reported that various chalcones possess cytotoxicity activity towards 
different tumor cell lines (Dimmock et al., 1999), but studies concerning their specific 
anticancer properties were very limited. In this project, the unsubstituted chalcone and 
5 hydroxychalcones: 2'-hydroxychalcone, 2-hydroxychalcone, 4-hydroxychalcone, 
4,2',4'-trihydroxychalcone and butein (3’4,2’，4，-tetrahydroxychalcone) were studied 
for their potential protective mechanisms against DMBA-induced carcinogenesis. 
Except for chalcone (Wattenberg, 1995) and 4-hydroxychalcone, the other four can be 
isolated from natural plants. 
n. Chalcones modulated Phase I enzyme activities 
Firstly, the regulatory effect of chalcones on the Phase I enzymes, especially 
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CYPlAl & IBl was studied. All the chalcone treatments were below the 
concentration of 10 pM, which didn't induce any significant cell death as indicated by 
M T T results. Except for 2-hydroxychalcone, all of the other five chalcones 
significantly decreased EROD activity in intact MCF-7 cells. This indicated their 
inhibitory effects on CYPl enzymes. 
All of the six chalcones showed competitive or noncompetitive inhibition on 
< 
CYPl enzyme activities, but their effects were more potent on CYPIBI enzyme 
activity than that of CYPlAl enzyme. Among them, 4,2',4'-trihydroxychalcone and 
butein did not inhibit CYPlAl enzyme, and 2-hydroxychalcone was the most potent 
inhibitory agent on CYPlAl inhibition while butein inhibited most on CYPIBI as 
shown in the Ki values. 
At the gene transcription level, the chalcones showed different regulatory effects 
on CYPl genes. Similar to the enzyme kinetics results, all of the six chalcones 
showed higher inhibitory potency on DMBA-induced CYPIBI gene expression than 
that of CYPlAl. Neither did 4,2‘,4'-trihydroxychalcone nor butein show any 
significant inhibition on CYPlAl gene expression as indicated by the XRE-luciferase 
and RT-PCR results. Among them, the unsubstituted chalcone and 
2'-hydroxychalcone were the most potent compounds on the inhibition of CYPlAl & 
IBl gene transcription. This effect might be due to their structural resemblance to 
PAHs, and they could act as PAH antagonist to inactivate the receptor, and blocked 
the CYPl enzyme gene transactivation pathway. 
The present results clearly showed that <1) chalcones could antagonize 
DMBA-induced carcinogenesis by modulating Phase I enzymes in MCF-7 cells; (2) 
they could inhibit CYPl at the enzyme activity level or gene transcription level, or 
both; (3) between these two inhibitory mechanisms, the effect on enzyme activity 
level appeared to be more essential; (4) chalcones were more effective on CYPIBI 
than CYPlAl enzyme inhibition; (5) different hydroxy substitutions of chalcone 
showed differential effects. The unsubstituted chalcone was the most potent one, 
followed by 2'-hydroxychalcone. Instead of inhibition, 2-hydroxychalcone induced 
CYPl enzyme activity in MCF-7 cells. 
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in. Chalcones regulated Phase II enzyme activities 
The Phase n drug metabolizing enzymes play an important role in the 
detoxification of potentially genotoxic radical or electrophilic chemicals by forming 
metabolite conjugates (Forum Symposium on Mechanisms of Action of Naturally 
Occurring Anticarcinogens, 1999). Because UGTs are mainly expressed in liver cells, 
a human liver cancer cell line HepG2 was also applied in this study to investigate the 
regulation of chalcones on Phase 11 enzymes. 
In HepG2 cells, all the tested chalcones significantly increased U G T enzyme 
activities in a dose-dependent manner. At the gene transcription level, chalcone, 
4,2',4'-trihydroxychalcone and butein significantly increased UGTlAl mRNA, while 
2' -hydroxychalcone and 2-hydroxychalcone did not induce this gene expression. 
These results indicated that the inducing effects of chalcones on UGT enzymes could 
be regulated at the gene transcription level. 
In MCF-7 cells, five chalcones showed significant induction of UGTlAl mRNA, 
while butein was not effective. Also not all of their effects were dose-dependent. 
Although the expression of UGTlAl gene in MCF-7 cells was much lower than that 
in HepG2 cells, the RT-PCR results also indicated the up-regulated gene expression 
by chalcones. These were consistent with the assay results in HepG2 cells. 
The inducing effects on Phase U enzymes, which lead to the detoxification of 
carcinogens from cells, can be an alternate mechanism of the chrmopreventive effect 
of chalcones. 
IV. Chalcones suppressed DMBA-induced DNA-adduct formation in MCF-7 
cells 
All of the tested chalcones, except for 2-hydroxychalcone, significantly 
decreased DMBA-induced DNA-adduct formation in MCF-7 cells in a 
dose-dependent manner. Among them, the unsubstituted chalcone was the most 
effective, which reduced DNA-adduct formation by 80% at the concentration of 10 
MM. However, the inhibitory effects of 4,2' ,4'-trihydroxychalcone and butein were 
rather modest. These results demonstrated that chalcones could suppress the 
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DNA-adduct formation and further prevented the accumulation of ultimate 
carcinogens. This could be another mechanism to definite chalcones as 
chemopreventive agents. 
V. The anti-carcinogenic properties of chalcones and their structures 
The present study showed that six chalcones displayed different enzyme 
regulatory effects. The difference might be related to the hydroxy group number and 
their position on the basic chalcone structure. Chalcones are a special group in the 
flavonoid family, and have a unique open-ring structure (Figure 3.14). This open ring 
might contribute to its chemopreventive properties. 
3' 1 1 
6' 
〇 
Figure 3 . 1 4 T h e basic chemical structure of chalcones. 
One study reported that the biological effects of chalcones depended on their 
chemical structures and only hydroxy substituted chalcones reduced ascites tumours 
in mice (Miranda et al., 1999). Another study illustrated that the maximum in vitro 
cytotoxicity exhibited in unsubstituded chalcones and chalcones substituted 
with -CH3 and /or - O H groups (Anto et al.，1995). The notion that unsubstituted 
chalcone and chalcones substituted with hydroxy groups have higher activity in tissue 
culture may be due to the increased permeability for the chalcones entering into the 
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cells (Anto et al.，1995). 
The position of hydroxy groups in chalcone structures is another important factor 
that determines their chemopreventive properties. The present result demonstrated 
that hydroxy group substitution at site C-2’ was most effective on CYPlAl/lBl 
enzyme inhibition, e.g. 2'-hydroxychalcone; while hydroxy substitute at site C-4' 
might alleviate inhibitory effects on CYPlAl enzyme activity, such as 
4,2' ,4' -trihydroxychalcone and butein. 
In summary, chalcones can prevent DMBA-induced carcinogenesis by reducing 
DNA-adduct formation, inhibiting Phase I enzymes and inducing Phase n enzymes. 
Their enzyme regulatory effects were at the enzyme activity level or/and gene 
transcription level. These properties could be determined by their chemical structures. 
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CHAPTER 4 EFFECTS OF PERILLYL 
ALCOHOL AND LIMONENE ON CYPl AND UGT 
ENZYMES 
Part One Introduction 
Monoterpenes are found in the essential oils of many plants including fruits, 
vegetables, and herbs (Gould, 1997). In citrus fruits, peppermint and other plants, 
d-limonene is formed by the cyclization of geranylpyrophosphate in a reaction 
catalyzed by limonene synthase. Limonene then serves as a precursor to other 
oxygenated monocyclic monoterpenes, such as carveol, carvone, menthol, perillyl 
alcohol (POH) and perillaldehyde (Crowell, 1999). These monoterpenes not only 
exhibit a very high degree of oral bioavailability in mammals, but also have been 
shown to exert chemopreventive and chemotherapeutic activities in mammary tumor 
models, and represent a new class of breast cancer therapeutic agents (Bardon et al.’ 
1998). 
D-Limonene is a prevalent flavoring agent for fruit juices, soft drinks, baked 
goods, ice cream and pudding. Orange oil, naturally consisting of 90-95% limonene, 
is a commercially available food flavoring agent. Limonene and/or its metabolites are 
detectable in serum, liver, lung and many other tissues (Crowell, 1999). Limonene has 
chemopreventive activity against mammary cancer during the initiation phase as well 
as the promotion and progression phases in rodents (Crowell et al, 1997). Limonene 
also increases the urinary excretion of the carcinogen D M B A and its metabolites by 
2.3-fold compared to control rats (B danger, 
httt)://www.thome.com/altmedrev/fulltext/alcohoB-6.htmD. It causes an 
approximately 50% tumor growth reduction at 5 m M (Karlson et al., 1996). Perillyl 
alcohol is 5 times more potent than limonene at inducing tumor regression (Haag & 
Gould, 1994). 
Perillyl alcohol is a monoterpene isolated from the essential oils of lavetidin, 
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peppermint, spearmint, cherries, celery seeds, and several other plants (Belanger et al., 
1998). Perillyl alcohol, also known as p-metha, L,7-diene-6-ol or 
4-isopropenyl-cyclohexenecarbinol, consists of two isoprene units synthesized in the 
mevalonate pathway. It may protect against colon cancer and other cancers by 
enhancing the detoxification of carcinogens in the liver (Belanger, 
http://www.thome.com/altmedrev/fulltext/alcohol3-6.htmli and it has been shown to 
induce the regression of 81% of small mammary carcinomas and up to 75% of 
advanced mammary carcinomas initiated by D M B A in Wistar-Furth rats (Haag & 
Gould, 1994). Perillyl alcohol prevents the interaction of chemical carcinogens with 
D N A by modulating carcinogen metabolism to the less toxic forms (Crowell, 1999). 
C H 2 O H C H 3 
H 3 C C H j H 3 C C H 2 
Perillyl Alcohol Li細nene 
Figure 4 .1Chemical structures of perillyl alcohol and limonene. 
D-Limonene is a monocyclic monopertene with perillyl alcohol a 
metabolite of d-limonene, being its hydroxylated form (Brudnak, 
http://www.positivehealth.com/permit/Articles/Cancer/bmd5 3. htm). 
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Part Two Results 
I . Perillyl alcohol and limonene modulated DMBA-induced CYPlAl/lBl 
activities in MCF-7 cells 
Perillyl alcohol inhibited EROD activity in MCF-7 cells with IC5o~2 [JM, but its 
effect was not dose-dependent. It was most effective at the concentration of 2.5 
with about 60% inhibition (Figure 4.2-1). 
4.2-1 
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Figure 4.2-1—Perillyl alcohol inhibited DMBA-induced EROD activity 
in MCF-7 cells. 
MCF-7 cells were seeded in 96-well culture plates and treated with 1 \iM 
D M B A and various concentrations of perillyl alcohol. After 24 hours of 
treatment, cells were assayed for EROD activity as described in Materials and 
Methods, *: P<0.05. Values are means ±SE, n=8. 
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Perillyl alcohol showed modest inhibition on microsomal EROD activiiy in 
MCF-7 cells. But its effect was not dose-dependent and was most effective at the 
concentration of 1 |LiM (Figure 4.2-2A). Limonene, on the other hand, 
dose-dependently inhibited MCF-7 microsomal EROD activity by 70% (Figure 
4.2-2B). 
DMBA-induced CYPl enzyme activity from MCF-7 
4.2-2 A microsomes , 
0 . 0 6 -1 
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0 1 2 3 4 5 6 7 8 9 1 0 1 1 
[Per i l l y l A l c o h o l ] ^iM 
4 2-26 DMBA-induced CYPl enzyme activity from MCF-7 
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Figure 4.2-2一Perillyl alcohol and limonene modulated DMBA-induced 
MCF-7 microsomal EROD activity. 
MCF-7 cells were treated with 1 jiM D M B A for 48 h, microsomes were 
extracted and were assayed for EROD activity with various concentrations of 
perillyl alcohol or limonene presented as described. *：尸<0.05; PcO.Ol. Values 
are means ±SE，n=3. 
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II. Perillyl alcohol and limonene regulated microsomal CYPlAl / IBl activities 
Perillyl alcohol did not show any inhibition on CYPlAl enzyme activity within 
the concentration of 2.5 |iM (Figure 4.3-1 A). 
4.3-lA 
\ Perillyl Alcohol 
I I 。 4 - • 。 -
^ 0.3 - ^ ^ ^ O 0.1 ^iM 
^ 0.2 - ^ T • l^ iM 
e ^^^ • 
i _ , , , , , . 
i -2 0 2 4 6 8 10 12 
O 
S l/[Ethoxyresorufin] (iiM)"^  
Figure 4.3-lA—Lineweaver-Burk plot of perillyl alcohol on microsomal 
CYPlAl enzyme activity regulation. 
E R O D activity in 2 pmoles of CYPlAl microsomes was measured in the 
presence of 100-1600 n M ER and the indicated concentrations of perillyl 
alcohol. Values are means ±SE, n=3. 
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Perillyl alcohol competitively inhibited CYPIBI enzyme activity with a Ki value 
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Figure 4.3-lB一Lineweaver-Burk plot of perillyl alcohol on microsomal CYPIBI 
enzyme activity inhibition. 
E R O D activity in 2.5 pmoles of CYPIBI microsomes was measured in the 
presence of 100-1600 nM ER and the indicated concentration of perillyl alcohol. 
Values are means 土SE，n二3. Ki value was derived by replotting the slopes obtained 
from the Lineweaver-Burk plot. 
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Limonene did not show any inhibition on CYPlAl enzyme activity within the 
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Figure 4.3-2A一Lineweaver-Burk plot of limonene on microsomal CYPlAl 
enzyme activity regulation. 
E R O D activity in 2 pmoles of CYPlAl microsomal protein was measured 
in the presence of 100-1600 nM ER and the indicated concentration of limonene. 
Values are means 土SE，n=3. 
91 
Chapter 6 
Neither did limonene show any competitive inhibition on CYPIBI enzyme 
activky within the concentration of 10 |iM (Figure 4.3-2B). 
4.3-2B 
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Figure 4.3-2B_Lineweaver-Burk plot of limonene on microsomal 
CYPIBI enzyme activity inhibition. 
E R O D activity in 2.5 pmoles of CYPIBI microsomes was measured in 
the presence of 100-1600 nM ER and the indicated concentration of limonene. 
Values are means ±SE, n=3. 
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in . Perillyl alcohol and limonene regulated DMBA-induced DNA adduct 
formation in MCF-7 cells 
Perillyl alcohol significantly decreased DMBA-induced D N A adduct formation 
when concentration reached 1 _， a n d its effect was dose-dependent. It decreased the 
D N A adduct formation by more than 90% at the concentration of 10 |iM (Figure 
4.4A). 
4.4A 
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Figure 4.4A——DMBA-DNA adduct formation in MCF-7 cells with perillyl 
alcohol treatment. 
MCF-7 cells were cultured in 6-well plates and treated with 0.1 |ig/ml 
[^H]DMBA and one of six perillyl alcohol concentrations: 0’ 0.5, 1, 5, 10, 25 ^LM, 
was co-administered. After 16 h of treatment, genomic D N A was isolated and the 
D M B A - D N A lesion was determined by scintillation counting. Values are means 
±SE, n=3. Means are significantly different (P<0.05) from the DMBA-treated 
control (0 |iM perillyl alcohol). 
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Compared with perillyl alcohol, there was no significant reduction of 
D M B A - D N A adduct formation was observed in limonene treatment (Figure 4.4B). 
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Figure 4.4B~DMBA-DNA adduct formation in MCF-7 cells with limonene 
treatment 
MCF-7 cells were cultured in 6-well plates and treated with [^H]DMBA in 
0.1 |ig/ml and one of six limonene concentrations: 0，0.5，1，5，10，25 \JM, was 
CO-administered. After 16 h of treatment, genomic D N A was isolated and the 
D M B A - D N A lesions were determined by scintillation counting. Values are means 
土SE, n=3. Means are significantly different (户<0.05) from the DMBA-treated 
control (0 fiM limonene). 
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IV. Perillyl alcohol and limonene regulated CYPlAl & CYPIBI gene expressions 
in MCF-7 cells 
Perillyl alcohol dose-dependently inhibited DMBA-induced CYPlAl and 
CYPIBI m R N A abundance. When administered at the concentration of 5 |iM, 60% 
of CYPlAl m R N A and 50% of CYPIBI m R N A were reduced, respectively (Figure 
4.5-1B&C). , 
4 1 u M DMBA+[Perillyl Alcohol] u M 
Control 0 0.5 1 5 
I I I 1 I I I 1 I 1 
I ...1 .1 .111 ^ ^ ^ ^ ^ l U l l i B H I i l i i B B B CYPlAl 
i S l S ^ i i a i i l l M i l i l g i ^ M ^ M ^ — "ctin 
4.5-lB 4.5-lC 
2 b 2.5 b 
1.8 - a b C C 
lfe[fiil::M”, 
0 L_2 0：5 1 LI 0 丨 0 0.5 1 5丨 
1 n M DMBA+[Pcnllyl Alcohol] fiM j ^ m DMBA+[PeriUyl Alcohol] ^ lM 
Figure 4.5-1—Effect of perillyl alcohol on DMBA-induced CYPlAl & IBl 
gene expression. 
MCF-7 cells were seeded in 6-well culture plates and treated with 1 |iM 
D M B A and perillyl alcohol for 24 h. Total R N A was then isolated and 
semi-quantitative RT-PCR was assayed to determine the relative m R N A 
expressions. Figure 4.5-1 A is the gel image of the ethidium bromide-stained 
amplified fragments. Figure 4.5-1 B & C were normalized optical density results for 
the CYPlAl and CYPIBI expressoins. Values are means ±SEM, n=3. Means with 
different letters differ (T<0.05). 
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Limonene did not affect DMBA-induced CYPlAl m R N A expression (Figure 
4.5-2B). It only slightly decreased CYPIBI m R N A at the concentration of 1 & 5 |iM， 
which represented around 20% reduction (Figure 4.5-2C). 
^^ 1 M DMBA+[Limonene] IJ M 
rnntrol 0 1 5 10 
I I I I"I丨|_||_|_I I丨|_|_|丨丨丨丨丨丨丨I I丨丨丨丨丨丨丨丨丨I I 
I M I I M I I i i i ^ ^ P ^ ^ M ^ ^ ^ ^ ^ ^ ^ f c H ^ M i CYPlAl 
C Y P I B I 
丨 丨 — ？ P -actin 
4.5-2B 4.5-2C 
b 
< 6 - b T b b 2.5] b a,b b 
I - 丄 鬥 • 由 < 2- _ T a，b i t 
< 4- [T| 1 _ I _ i _ 
• 3. I 1 . a _ _ 
I B 1- i i ^ 
2 - a � 
“ i f t 1 1 1 1 I I I 11 畫 : u . i , i i I 
0 0 1 5 10 0 0 1 5 1 0 
I I I I 
IjiM DMBA+[Limonene] ^ M 1 ^m DMBA+[Limonene] ^ M 
Figure 4.5-2—Effect of limonene on DMBA-induced CYPlAl & IBl gene 
expression. 
MCF-7 cells were seeded in 6-well culture plates and treated with 1 |iM D M B A 
and limonene for 24 h. Total R N A was then isolated and semi-quantitative RT-PCR 
was assayed to determine the relative m R N A expressions. Figure 4.5-2A is the gel 
image of the ethidium bromide-stained amplified fragments. Figure 4.5-2B&C were 
normalized optical density results for the CYPlAl and CYPIBI expressions. Values 
are means ±SEM’ n=3. Means with different letters differ (P<0.05). 
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V. Effect of perillyl alcohol on CYPlAl XRE transactivation 
Similar to the CYPlAl RT-PCR result, perillyl alcohol did not show any 
inhibition on DMBA-induced XRE transactivation. This result demonstrated that 
perillyl alcohol had no effects on XRE transactivation pathway (Figure 4.6). 
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Figure 4.6—Effect of perillyl alcohol on DMBA-induced CYPlAl XRE 
transactivation. 
MCF-7 cells were seeded in 6-well culture plates and transiently transfected 
with a luciferase reporter gene containing XRE and a pRL plasmid as control. The 
transfected cells were then treated with 1 |xM D M B A and co-treated with perillyl 
alcohol (control received D M S O only) for 24 h. Values are means 土SEM，n=3. 
Means without same letters differ (户<0.05). 
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VI. Cytotoxic effect of perillyl alcohol aiMl limonene on MCF-7 cells 
Neither perillyl alcohol nor limonene demonstrated cytotoxic to MCF-7 cells for 
the concentrations tested (Figure 4.7). 
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Figure 4.7~The cytotoxic effect of DMBA, perillyl alcohol and limonene on 
MCF-7 cells. 
MCF-7 cells were cultured in 96-well plates. 1 |JM DMBA was added to the 
cultures, perillyl alcohol and limonene ranging from 0 |JM (control) to 10 pM 
was co-administered with DMBA. After 72 h of treatment, the cell viability was 
measured by MTT assays. Values are means 士SE, n=8. 
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Vn. Perillyl alcohol and limonene modulated UGTlAl gene expression in MCF-7 
cells 
Perillyl alcohol significantly increased the UGTlAl gene expression in MCF-7 
cells. At the concentration of 0.5 |JM, UGTlAl m R N A was increased by around 2 
fold (Figure 4.8-1). 
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Figure 4.8-1—Effect of perillyl alcohol on DMBA-induced UGT lAl gene 
expression in MCF-7 cells. 
MCF-7 cells were seeded in 6-weU culture plates and treated with 1 |iM 
D M B A and perillyl alcohol for 24 h. Total R N A was then isolated and 
semi-quantitative RT-PCR was assayed to determine the relative m R N A 
expressions. Figure 4.8-1 A is the gel image of the ethidium bromide-stained PGR 
fragments. Figure 4.8-lB was the optical densky results of the amplified 
UGTlAl fragments from RT-PCR. Values are means 土SEM, n=3. Means with 
different letters differ fP<0.05). 
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Limonene didn't increase DMBA-induced UGTlAl mRNA in MCF-7 cells 
(Figure 4.8-2). 
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Figure 4.8-2—Effect of limonene on DMBA-induced UGT lAl gene 
expression in MCF-7 cells. 
MCF-7 cells were seeded in 6-well culture plates and treated with 1 |iM 
DMBA and various concentrations of limonene for 24 h. Total RNA was then 
isolated and semi-quantitative RT-PCR was used to determine the relative 
mRNA expressions. Figure 4.8-2A is the gel image of the ethidium 
bromide-stained PGR fragments. Figure 4.8-2B was the optical density results 
of the amplified UGTlAl fragments from RT-PCR. Values are means 士SEM, 
n=3. Means with different letters differ (P<0.05). 
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VID. Perillyl alcohol and limonene modulated UGT enzyme in HepG2 cells 
Perillyl alcohol significantly increased UGT enzyme activity in HepG2 cells. It 
was most effective at the concentration of 0.5 |iM, which UGT activity was increased 
by 6.5 fold (Figure 4.9-lA). Perillyl alcohol also showed a strong induction of 
UGTlAl gene expression in HepG2 cells. It could at most increase UGTlAl m R N A 
by nearly 3 times at the concentration of 1 |iM (Figure 4.9-1B&C). ‘ 
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Figure 4.9-1 A—Effect of perillyl alcohol on UGT enzyme activity in HepG2 
cells. 
HepG2 cells were cultured in phenol-red free RPMI-1640 medium for 3 days, 
then they were treated with perillyl alcohol ranging from 0 (control) to 10 |iM in the 
presence of 1 |iM D M B A for 48 h. Microsomes were extracted as described above. 
0.2 mg microsomes was applied in each reaction and p-nitrophenol was used as the 
substrate, and the samples were incubated at 37°C for 0，5，10’ 20 min respectively. 
The activity was measured by the absorbance at 400 nm. The calculation formula 
was described in Materials and Methods. Values are means 土SEM，n=3. Means with 
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Figure 4.9-1B&C—Effect of perillyl alcohol on DMBA-induced UGT lAl 
gene expression in HepG2 cells. 
HepG2 cells were seeded in 6-well culture plates and treated with 1 |iM 
D M B A and perillyl alcohol for 24 h. Total R N A was then isolated and 
semi-quantitative RT-PCR was assayed to determine the relative m R N A 
expressions. Figure 4.9-lB is the gel image of the ethidium bromide-stained PCR 
fragments. Figure 4.9-1 C was the optical density results of the amplified UGTlAl 
fragments from RT-PCR. Values are means ±SEM，n=3. Means with different 
letters differ (P<0.05). 
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Limonene significantly increased UGT enzyme activity in HepG2 cells at all 
concentrations. It was also most effective at the concentration of 0.5 |LIM, which 
increased the U G T activity by 7-fold (Figure 4.9-2A). Limonene showed modest 
induction of UGTlAl gene expression in HepG2 cells It could at most increase 25% 
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Figure 4.9-2A——Effect of limonene on UGT enzyme activity in HepG2 cells. 
HepG2 cells were cultured in phenol-red free RPMI-1640 medium for 3 day, 
then they were treated with limonene ranging from 0 (control) to 10 |iM in the 
presence of 1 |LIM D M B A for 48 h. Microsomes were extracted as described 
above. 0.2 mg microsomes was applied in each reaction and /7-nitrophenol was 
used as the substrate, and the samples were incubated at 37°C for 0，5，10，20 min 
respectively. The activity was measured by the absorbance at 400 nm. The 
calculation formula was described in Materials and Methods. Values are means 
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Figure 4.9-2B&C—Effect of limonene on DMBA-induced UGT lAl gene 
expression in HepG2 cells. 
HepG2 cells were seeded in 6-well culture plates and treated with 1 fiM 
D M B A and limonene for 24 h. Total R N A was then isolated and semi-quantitative 
RT-PCR was used to determine the relative m R N A expressions. Figure 4.9-2B is 
the gel image of the ethidium bromide-stained PGR fragments. Figure 4.9-2C was 
the optical density results of the amplified UGTlAl fragments from RT-PCR. 
Values are means 土SEM，n=3. Means with different letters differ (?<0.05). 
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Perillyl alcohol Limonene 
C Y P l A l EROD activity Inhibition Inhibition 
& IBl Enzyme kinetics CYPIBI inhibition No inhibition 
(Ki〜0.47 |iM) 
D N A adduct formation 90% Inhibition No inhibition 
Gene expression 50-60% Inhibition No inhibition 
U G T Enzyme activity 6.5-Fold induction 7-Fold induction 
(lAl) Gene expression Induction No induction 
Table 4.1—Comparison of perillyl alcohol and limonene on Phase I & Phase 
U enzyme regulation. 
Perillyl alcohol inhibited CYPlAl&lBl and induced UGT enzymes both at 
enzyme activity and gene expression levels. While limonene could only decrease 
E R O D activity in MCF-7 cells and increased U G T enzyme activity in HepG2 
cells, but it had no effect at gene expression level. 
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Part Three Discussion 
Numerous studies have demonstrated the anticancer effects of the monoterpene 
perillyl alcohol and limonene, which cause both cytostasis and apoptosis in rat 
mammary carcinomas. In vitro, they inhibit cellular proliferation in many mammalian 
cell lines (Shi & Gould, 2002). Phase I and Phase n clinical trials of the 
chemotherapeutic• activity of perillyl alcohol and limonene on breast cancer patients 
are being in progress (Lluria-Prevatt et al., 2002). Additionally, multiple Phase II 
clinical trials are now in progress, too (Ariazi et al•，1999 & Low-Baselli et al, 2000). 
The effects of perillyl alcohol and limonene on Phase I and Phase n enzymes were 
investigated in a cell culture model in the present study. 
Although the use of perillyl alcohol for the chemoprevention against human 
carcinogenesis has been proposed, the effects of perillyl alcohol in early 
carcinogenesis is unclear. The Phase I enzymes, CYPlAl and CYPIBI were reduced 
by perillyl alcohol in intact MCF-7 cells. Enzyme kinetics results revealed that 
perillyl alcohol competitively inhibited CYPIBI but not CYPlAl enzyme activity, 
while RT-PCR assay showed a dose-dependent inhibition on both CYPlAl and 
CYPIBI gene expression. The XRE-luciferase assay indicated that perillyl alcohol 
didn't affect XRE-dependent transactivation pathway. In addition, perillyl alcohol 
demonstrated a dose-dependent inhibition on DMBA-DNA adduct formation. This 
result suggested its protection against the PAH-induced carcinogenesis pathway might 
not be due to its interruption of Ah receptor activation. Perillyl alcohol could disrupt 
Phase I enzyme, and CYPIBI was specifically inhibited both at the enzyme activity 
and gene expression levels. It also induced UGT enzyme activity and UGTlAl 
m R N A expression in HepG2 cells and MCF-7 cells. The results demonstrated that the 
effect of perillyl alcohol on the Phase 11 enzyme also contributed to its 
chemopreventive effects. 
As reported by several studies, limonene inhibits the development of 
chemical-induced mammary cancer in rodent models, and the chemopreventive effect 
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of limonene is introduced during the initiation phase (Crowell, 1999). The induction 
of enzymes that inactivate the carcinogen can be the mechanism involved 
(Low-Baselli et al., 2000). However, limonene didn't inhibit CYPlAl and CYPIBI 
m R N A or enzyme activities in the present study, and it could not reduce the 
DMBA-DNA adduct formation. It significantly increased microsomal UGT enzyme 
activity in MCF-7 cells. This suggested that the anti-carcinogenesis effects of 
5 
limonene were predominantly on the induction of Phase n enzyme activities. 
Cancer can be prevented through various mechanisms. These mechanisms 
include reducing metabolic toxification and/or enhancing detoxification, which can 
lower the amount of ultimate carcinogen (Low-Baselli et al., 2000). In the 
post-initiation phase, tumor suppressive activity of monoteipenes may induce 
apoptosis and inhibit cell growth by interfering the post-translational isoprenylation of 
Ras oncoproteins (Karlson et al, 1996). The chemopreventive effects of perillyl 
alcohol and limonene are attributable to the induction of Phase n metabolizing 
enzymes (Crowell, 1999). Liver cells have a higher Phase II enzyme activity, 
especially the UGT enzymes, than the other tissues (Guillemette et al., 2000). In the 
present study, human liver HepG2 cancer cells were also investigated. Both perillyl 
alcohol and limonene could significantly increase UGT activity and m R N A 
abundance in HepG2 cells similar to the results observed in MCF-7 cells. This result 
revealed that the induction of UGT enzyme was also mechanism in antagonizing 
DMBA-induced carcinogenesis. 
In spite of the structural resemblance, perillyl alcohol showed a stronger 
inhibition on both Phase I and Phase n enzymes than limonene. This result was 
consistent to a former research, which showed that perillyl alcohol was at least five 
times more potent than limonene in inhibiting rat mammary carcinogenesis 
(Low-Baselli et al., 2000). An additional hydroxy-group in the structure of perillyl 
alcohol, increased the polarity of the molecule, and made it easier to bind with the 
PAH receptor than limonene. Perillyl alcohol could then antagonize D M B A to 
regulate the CYPl gene expression, and possibly contributed mostly to the higher 
inhibition on DMBA-induced carcinogenesis than that of limonene. 
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In summary, perillyl alcohol protected against DMBA-induced carcinogenesis by 
inhibiting Phase I and inducing Phase EE enzymes. 
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CHAPTER 5 LYCOPENE MEDIATED 
DMBA-INDUCED PHASE I & PHASE H ENZYME 
ACTIVITIES AND GENE EXPRESSIONS 
Part One Introduction 
I. Biochemical properties of lycopene 
Lycopene, a carotenoid in the same family as beta-carotene, is what gives 
tomatoes, pink grapefruit, apricots, red oranges, watermelon, rosehips，and guava their 
red color. Lycopene is not merely a pigment. It is a powerful antioxidant that has been 
shown to neutralize free radicals, especially those derived from oxygen, and thereby 
conferring protection against prostate cancer, breast cancer, atherosclerosis and the 
associated coronary artery disease. It reduces LDL (low-density lipoprotein) oxidation 
and helps reducing cholesterol level in the blood. In addition, preliminary researches 
suggest lycopene may reduce the risk of macular degenerative disease, serum lipid 
oxidation, and cancers of the lung, bladder, cervix, and skin. The chemical properties 
of lycopene, which may be responsible for these protective actions are 
well-documented (http://che.mistrv. abont.com/librarv/weeklv/aa050401 a.htm). 
1 
Lycopene 
Molecular Weight: 536.89 
Molecular Formula: C40H55 
Figure 5.1—Chemical structure of lycopene. 
Lycopene is an acyclic isomer of beta-carotene. This highly unsaturated 
hydrocarbon contains 11 conjugated and 2 unconjugated double bonds, making it longer 
than any other carotenoid ChttpV/chemistry.about.conVlibrary/weekly/aa050401a.htm). 
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II. Bioavailability of lycopene 
Blood concentration of carotenoids has been proposed as an integrated 
biochemical marker of vegetable, fruit, and synthetic supplements consumed (Toniolo 
et al., 2001). Lycopene is the most predominant carotenoid in human plasma, and is 
present naturally in greater amount than beta-carotene and other dietary carotenoids. 
Because lycopene is fat-soluble (as vitamins A, D, E, and beta-carotene), absorption 
into tissues is improved when oil is added to the diet 
dittpV/cheinistrv. about.com/librarv/weeklv/aa()5()4()l a.htm). It is clear that lOOO-fold 
more lycopene is absorbed and stored in the liver than accumulates in other target 
organs. Nonetheless, physiologically significant (nanogram) levels of lycopene are 
assimilated by key organs such as breast, prostate, lung, and colon, and there is a 
rough dose-response relationship between lycopene intake and blood levels (Cohen et 
al., 2002). Two oxidative metabolites of lycopene, 2,6-cyclolycopene-l,5-diols A and 
B, which are only present in tomatoes in extremely low concentrations, have been 
isolated and identified in human serum, milk, liver, lung, breast, prostate, colon and 
skin (Khachiket al., 2002). 
EQ. Lycopene and cancers in hormonal sensitive tissues 
The reported antioxidant activities of lycopene include singlet-oxygen quenching, 
peroxyl-radical scavenging, and it induces cell-cell communication and growth 
control (Livny et al., 2002). Studies have shown that low dietary intake of carotenoids 
is associated with an increased risk of breast cancer (Prakash et al., 2001). There is a 
dose-response protection of breast cancer with a threshold effect for lycopene (Sato et 
al., 2002). Carotenoids inhibit the proliferation of human breast cancer MCF-7 cells in 
vitro, especially lycopene. Between 10 and 20 M, lycopene reduces the number of 
MCF-7 cells by 87.8%. The action of carotenoids may be executed through different 
pathways (Li et al., 2002). Lycopene also inhibits human prostate cancer cell growth 
by interfering with growth factor receptor signaling and cell cycle progression, and 
there is no evidence of toxic or apoptotic effects to normal cells (Heber & Lu，2002). 
110 
Chapter 6 
Part Two Results 
I Lycopene modulated DMBA-induced CYPlAl/lBl activities in MCF-7 cells 
Lycopene modestly inhibited EROD activities in MCF-7 cells，and its effect was 
not dose-dependent. It was most effective at the concentration of 1 ^ M with about 
30% inhibition (Figure 5.2-1). 
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Figure 5.2-1 — Lycopene inhibited DMBA-induced EfeOD activity in 
MCF-7 cells. 
MCF-7 cells were seeded in 96-weU culture plates and treated with 1 一 
D M B A and lycopene. After 24 h of treatment, cells were assayed for E R O D 




Lycopene significantly dose-dependently inhibited MCF-7 microsomal EROD 
activity by more than 70% at the concentration of 10 |iM (Figure 5.2-2). 
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Figure 5.2-2—Lycopene decreased DMBA-induced MCF-7 microsomal 
EROD activity. 
MCF-7 cells were treated with 1 }jJM D M B A and lycopene for 48 h, 
microsomes were extracted and assayed for EROD activity as described in 
Materials and Methods, *:户<0.05; **: P<0.01. Values are means 土SE，n=3. 
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II. Lycopene competitively inhibited microsomal CYPlAl & CYPIBI activities 
Lycopene competitively inhibited CYPlAl enzyme activity with a Ki value of 
-9.86 \JiM (Figure 5.3A). 
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Figure 5.3A—Lineweaver-Burk plot for lycopene's inhibition on microsomal 
CYPlAl enzyme activity. 
E R O D activity in CYPlAl microsomes was measured in the presence of 
100-1600 nM ER and the indicated concentrations of lycopene. Values are means 
±SE, n=3. Ki value was derived from the replot of the slopes obtained by linear 
regression of data from the Lineweaver-Burk plot. 
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Lycopene competitively inhibited CYPIBI enzyme activity with a Ki value of 
~14.6|iM (Figure 5.3B). 
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Figure 5.3B一Lineweaver-Burk plot for lycopene's inhibition on microsomal 
CYPIBI enzyme activity. 
E R O D activity in CYPIBI microsomes was measured in the presence of 
100-1600 n M ER and the indicated concentrations of lycopene. Values are means 
±SE, n=3. Ki value was derived from the replot of the slopes obtained by linear 
regression of data from the Lineweaver-Burk plot. 
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EQ. Lycopene suppressed DMBA-induced DNA adduct formation in MCF-7 cells 
Lycopene significantly reduced DMBA-induced D N A adduct formation in a 
dose-dependent manner. It decreased the D N A adduct formation by 50% at the 
concentration of 5 |LIM (Figure 5.4). 
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Figure 5.4~DMBA-DNA adduct formation in MCF-7 cells with lycopene 
treatment. 
MCF-7 cells were cultured in 6-well plates and treated with 0.1 [Xg/rnl 
[^H]DMBA and one of 6 lycopene concentrations: 0, 0.1, 0.5, 1’ 2.5, 5 |iM, was 
CO-administered. After 16 h of treatment, genomic D N A was isolated and the 
D M B A - D N A lesion was determined by scintillation counting. Values are means 




IV. Lycopene regulated CYPlAl & CYPIBI gene expression in MCF-7 cells 
Lycopene could not affect CYPlAl gene expression (Figure 5.5B). It decreased 
CYPIBI m R N A by 50% at the concentration of 5 |iM (Figure 5.5C). 
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Figure 5.5—Effect of lycopene on DMBA-induced CYPlAl & CYPIBI gene 
expression. 
MCF-7 cells were seeded in 6-weU culture plates and treated with 1 |iM D M B A 
and lycopene for 24 h. Total R N A was then isolated and semi-quantitative RT-PCR 
was assayed to determine the relative m R N A expressions. Figure 5.5A is the gel 
image of the ethidium bromide-stained PGR fragments. Figure 5.5B and C were 
optical density results of the CYPlAl and CYPIBI amplified fragments from 
RT-PCR. Values are means 土SEM，n=3. Means with different letters differ (P<0.05). 
116 
Chapter 6 
V. Effect of lycopene on CYPlAl XRE trasactivation 
Similar to CYPlAl RT-PCR result, lycopene did not show any inhibition of 
DMBA-induced XRE transactivation (Figure 5.6). 
Figure 5.6 
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Figure 5.6—Effect of lycopene on DMBA-induced CYPlAl XRE 
transactivation. 
MCF-7 cells were seeded in 6-well culture plates and transiently transfected 
with a luciferase reporter gene containing CYPlAl XRE plasmid and a pRL 
plasmid as control, then treated with 1 |iM D M B A and lycopene for 24 h. Values 
are means 土SEM，n=3. Means without same letters differ (尸<0.05). 
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VI. Cytotoxic effect of lycopene on MCF-7 cells 
Below the concentration of 5 foM, lycopene did not show any significant 
cytotoxic effect on MCF-7 cells (Figure 5.7). 
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Figure 5.7—The cytotoxic effect of DMBA and lycopene on MCF-7 cells. 
MCF-7 cells were cultured in 96-well plates. 1 }JM DMBA was added to the 
cultures, and lycopene ranging from 0 p M (control) to 5 j j M was 
co-administered with D M B A . After 72 h of treatment, the cell viability 
percentage was determined by M T T assay. Values are means 士SE，n=8. 
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Vn. Lycopene modulated UGT enzyme in MCF-7 cells 
Lycopene significantly increased UGT enzyme activity in MCF-7 cells, but its 
effect was not dose-dependent. 4-Fold induction of UGT activity was observed at the 
concentration of 1 |aM (Figure 5.8A). It also significantly increased the UGTlAl 
gene expression. The UGTlAl m R N A was increased by nearly 2 fold at the 
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Figure 5.8A一Effect of lycopene on UGT enzyme activity in MCF-7 cells. 
MCF-7 cells were cultured in phenol-red free RPMI-1640 medium for 3 days, 
then treated with lycopene ranging from 0 (control) to 5 |iM in the present of 1 |iM 
D M B A for 48 h. Microsomes were extracted as described in Materials and Methods. 
0.2 mg microsomes was applied in each reaction and /?-nitrophenol was used as the 
substrate. The reactions were incubated at 37。C for 0，5，10，20 min and the 
respective absorbance was measured at 400 nm. The calculation formula was also 
described in Materials and Methods. Values are means 土SEM，n=3. Means with 
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Figure 5.8B&C—Effect of lycopene on DMBA-induced UGT lAl gene 
expression in MCF-7 cells. 
MCF-7 cells were seeded in 6-weU culture plates and treated with 1 |iM D M B A 
and lycopene for 24 h. Total R N A was then isolated and semi-quantitative RT-PCR 
was assayed to determine the relative m R N A expressions. Figure 5.8B is the gel 
image of the ethidium bromide-stained PGR fragments. Figure 5.8C was the optical 
density results of the amplified UGTlAl fragments from RT-PCR. Values are means 
±SEM, n=3. Means with different letters differ (户<0.05). 
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Vffl. Lycopene modulated UGT enzyme in HepG2 cells 
Lycopene significantly increased UGT enzyme activky in HepG2 cells, and the 
effect was dose-dependent. The induction was most effective at the concentration of 
2.5 |iM, which increased the activity by 2.5-fold (Figure 5.9A). Lycopene also 
showed a strong induction of UGTlAl gene expression in HepG2 cells, and the effect 
was dose-dependent. It could increase UGTlAl m R N A by nearly 7-fold at the 
concentration of 2.5 ^ iM (Figure 5.9B&C). 
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Figure 5.9A——Effect of lycopene on UGT enzyme activity in HepG2 cells. 
HepG2 cells were cultured in phenol-red free RPMI-1640 medium for 3 days, 
then treated with lycopene ranging from 0 (control) to 5 jiM in the present of 1 |iM 
D M B A for 48 h. Microsomes were extracted as described in Materials and Methods. 
0.2 mg microsomes was applied in each reaction and p-nitrophenol was used as the 
substrate. The reactions were incubated at 37°C for 0，5，10，20 min and the 
absorbance reading at 400 nm was measured. The calculation formula was also 
described in Materials and Methods. Values are means ±SEM，n=3. Means with 
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Figure 5.9B&C—Effect of lycopene on DMBA-induced UGT lAl gene 
expression in HepG2 cells. 
HepG2 cells were seeded in 6-well culture plates and treated with 1 |j.M 
D M B A and lycopene for 24 h. Total R N A was then isolated and semi-quantitative 
RT-PCR was assayed to determine the relative m R N A expressions. Figure 5.9B is 
the gel image of the ethidium bromide-stained PGR fragments. Figure 5.9C is the 
optical density results of the amplified UGTlAl fragments. Values are means 
±SEM，n=3. Means with different letters differ (P<0.05). 
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Part Three Discussion 
Epidemiologic and laboratory investigations have suggested an inverse 
correlation between consumption of fruits and vegetables rich in carotenoids and 
certain cancer incidence rates. Carotenoids may act as chemoprotective agents 
through biological activities such as antioxidation, immunoenhancement, and many 
protect against mutagenesis, malignant transformation, and tumorigenesis (Prakash et 
al., 2001). These observations offer evidence that a low intake of carotenoids, through 
poor diet and/or lack of vitamin supplementation, may be associated with increased 
risk of breast cancer and may have public health relevance for people with markedly 
low intakes (Toniolo et al., 2001). 
The present research work was focused on the anticancer effects of lycopene 
because it had been shown to be more potent than a - or 3 -carotene in inhibiting 
tumor cell growth in cell cultures and in animal models (Kris-Etherton et al., 2002), 
While the chemical properties of lycopene have been studied，the anticarcino genie 
mechanisms of lycopene remain speculative. Its antioxidant properties may interfere 
with oxidative damage to lipids, DNA, and lipoproteins (Kris-Etherton et al., 2002), 
and it is possible that lycopene inhibits cancer cell growth at different pathways. 
Several assays were designed in this study to investigate the protective mechanisms of 
lycopene against chemical carcinogenesis. A study has shown that 10 P M lycopene 
significantly inhibits the MCF-7 cell growth in vitro (Li et al, 2002). Therefore, 
lycopene concentrations between 0 to 5 P M were chosen in this study. MT T assay 
result also illustrated that no significant effect on MCF-7 cell viability was seen 
within this dose range. 
Diet-derived antioxidants have been proposed to be protective against breast 
cancer mainly on the basis of their ability to reduce DNA damage (Ching et al, 2002). 
In this study, lycopene reduced 50% of DMBA-DNA adducts in MCF-7 cells at a 
concentration of 5 u M. 
EROD assay revealed that CYPl enzyme activity was inhibited by 30% in intact 
MCF-7 cells, and 60% inhibition in MCF-7 microsomes. Subsequent investigations 
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addressed whether the inhibition occurred at the CYPl enzyme activity level or gene 
regulation level, or both. The results indicated that lycopene competitively inhibited 
both CYPlAl and CYPIBI enzyme activities. The comparison on Ki values showed 
that lycopene was more potent in inhibiting CYPlAl enzyme activity than that of 
CYPIBI. No effect of lycopene was observed on XRE transactivation, nor CYPlAl 
gene expression. It reduced 50% of CYPIBI m R N A at the concentration of 5 u M. 
The above results suggested that lycopene could reduce DMBA-induced 
carcinogenesis by inhibiting CYPlAl & IBl at the enzyme activity level, and had 
modest effect on CYPl gene regulation. 
It has been hypothesized that lycopene derivatives may act as ligands for a 
nuclear receptor in analogy to retinoic acid, a hormone derived from P -carotene. The 
inhibitory effect of lycopene on MCF-7 cell growth is related to the interference in the 
signaling pathways (Ben-Dor et al., 2001). Lycopene increased the UGTlAl gene 
expression by 2-fold in MCF-7 cells, which could help eliminating the 
DMBA-attacking metabolites. 
UGT enzymes are mainly expressed in the liver. The effect of lycopene on UGT 
enzyme in the human liver HepG2 cancer cells was also investigated. The result 
revealed that lycopene could significantly increase UGT enzyme activity (around 2.5 
fold) and UGTlAl m R N A (nearly 7 fold). This indicated lycopene's potent protection 
against DMBA-induced carcinogenesis. 
However, not all studies led to the similar conclusion. A study on African 
American women reports a weak inverse association between plasma lycopene levels 
and breast cancer risk (Simon et al., 2000). Another study documents that there is no 
clear association between intake of a -& p -carotenes, lycopene or lutein and breast 
cancer risk in the study population as a whole or in subgroups defined by smoking 
status; relative body weight; intakes of total fat, energy, alcohol, or folic acid; family 
history of breast cancer; or menopausal status (Terry et al, 2002). However, the 
present results presented above support the point that lycopene holds some anticancer 




CHAPTER 6 CHALCONES AND PERILLYL 
ALCOHOL REGULATED CYPlAl & CYPIBI 
MEDIATED ESTRADIOL METABOLIZING 
PATHWAYS 
Part One Introduction 
I . Estrogen hydroxylation and human breast cancer risk 
Prolonged exposure to high estrogen level has been associated with an elevated 
incidence of female breast cancer (Henderson et al, 1991). Estrogens (estrone and 
17|3-estradiol) can play dual roles in the induction of cancer: generation of 
electrophilic species that can covalently bind to D N A to induce mutations, and 
stimulation of cell proliferation by receptor-mediated processes. Estrogens are mainly 
metabolized via two main pathways: 16a-hydroxylation and formation of catechol 
estrogens (CE). Epidemiological study indicates that CE formation may be a greater 
risk factor for breast cancer than 16a-hydroxylation of estrogens, and the reason is 
related to D N A damage induced by CE metabolites (Todorovic et al., 2001). 
The effects of estradiol in carcinogenesis may depend on individual variations in 
estradiol metabolism (Mueck et al, 2002). In a study on premenopausal women, a 
higher 2- / 16a-hydroxyestradiol ratio in urine was correlated with a reduced risk of 
breast cancer (Lord & Bralley’ 2002). Tumors usually develop from tissues where 
estradiol is predominantly converted to 4-hydroxyestracliol, whereas organs favoring 
2-hydroxylation of estradiol do not develop tumor. Elevated formation of 
4-hydroxylated estrogens in estrogen target organs may increase the risk of 
hormone-dependent oncogenesis. Moreover, an elevated ratio of 4- / 
2-hydroxyestradiol formation in neoplastic mammary tissue may therefore provide a 
useful marker for benign or malignant breast tumors and may implicate the 
significance of 4-hydroxyestradiol in tumor development (Liehr & Ricci，1996). 
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II. CYPl enzymes catalyze estradiol-hydroxylation in human breast cancer cells 
Isoenzymes of the cytochrome P450 family protein can insert hydroxy! groups at 
the 2-C, 4-C, or 16-C positions of estrogen (Lord & Bralley，2002). CYPlAl mainly 
hydroxylates estradiol to 2-hydroxyestradiol (Chun et al.，2001), while CYPIBI 
catalyzes the metabolism of estradiol to 2-hydroxyestradiol and 4-hydroxyestradiol 
(Li et al., 2000). 
Elevated 4-hydroxylase enzyme activity has been found in human breast cancer 
specimens (Mueck et al., 2002)，while a significant amount of CYPIBI is also 
demonstrated (Liehr & Ricci，1996). This activity is not detected in normal breast 
tissue, where estradiol is mainly metabolized by 2-hydroxylation. Estradiol 
4-hydroxylation appears to be a reaction specifically catalyzed by human CYPIBI 
(Murray et al., 2001). 
in. Phytochemicals mediate estrogen-hydroxylation pathways 
The basic strategy to diminish the effects of estrogen is blocking its binding to 
the estrogen receptor (Wong et al, 1998). Flavonoids, which are structurally similar to 
estrogens, are able to compete with estrogen for the binding to estrogen receptor. 
Therefore, flavonoids may prevent cancer, particularly estrogen-dependent breast 
cancer (Le Bail et al., 1998). An optimal pattern of hydroxylation seems to be 
necessary for a flavonoid to have estrogenic activity (So et al., 1997). 
The technique of high performance liquid chromatography (HPLC) had been 
adopted for estradiol metabolites detection and separation (Badawi et al” 2000). 
Because of the low sensitivky of U V detector, [^ H] labeled estradiol was used as the 
substrate and a scintillation detector was employed to detect the estradiol metabolites 
(Mesia-Vela et al.，2002). 
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Part Two Estrogen metabolite detection and separation by HPLC 
All the estradiol metabolites showed the strongest U V absorbance at 230 nm. 
Among them，the peak of 16 a -OHE2 came first at 〜7 min, then 4-OHE2 at 〜16 min, 
followed by 2-OHE2 at -20 min, the mixture of 4- & 2-OHEi peak was 〜24 min, 
finally were the peaks of E2 〜33 min and Ei -43 min (Figure 6,1). 
• 〜 . 一 _ 
• " ^ ― — 
-.-一 - — 
230 nm 产 Txi • l^-OHEz 
Figure 6.1~~A 3D graph of estrogen metabolite separated and detected by a 
HPLC-UV method. 
Mixtures of estrogen metabolites were separated by a Cig column (SUPELCO, 
Bellefonte, PA, USA) with flow rate of 1 ml/min. The mobile phase comprised: 58.5% 
ddH20, 20% methanol, 20% acetonitrile and 1.5% acetic acid, and filtered and degassed 
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Figure 6.2~Standard curves of estradiol and its metabolites. 
The curves are in a relationship of compound amounts and peak areas by a U V 
detector at 230 nm. 
6.2A: Estradiol; 6.2B: 16 a -Hydroxyestradiol; 
6.2C: 4-Hydroxyestradiol; 6.2D: 2-Hydroxyestradiol 
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Part Three Results 
I . Perillyl alcohol modulated CYPlAl & IBl-mediated estradiol-hydroxylation 
(Figure 6.3) 
Each reaction was composed of reaction buffer (5 m M MgCli, 2 m M ascorbic 
acid, 100 m M NaHzPO*，PH 7.4)，perillyl alcohol (0’ 0.5 1，5，10 [iM), 50 n M [^ H] 
labeled estradiol as the substrate, 10 pmole human recombinant CYPlAl/lBl 
microsomes. The reaction was pre-incubated at 37 ®C for 5 min, then 1.4 m M 
(3-NADPH was added to trigger the reaction at 37 °C for another 15 min. Ice cold 
ascorbic acid was added to terminate the reaction. The hydroxylation products were 
extracted by ethyl acetate twice, then dried by nitrogen gas, redissolved in methanol 
to do HPLC assay by a radioactivity detector as described above. 
6.3A 
Effect of perillyl alcohol on CYPlAl-mediated estradiol 
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Figure 6.3A—Effect of perilly alcohol on CYPlAl-mediated estradiol 
hydroxylation. 
Perillyl alcohol mainly inhibited CYPlAl-mediated 2-hy(iroxylation, but 





Effect of perillyl alcohol on CYPIBI-mediated estradiol 
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Figure 6.3B—Effect of perillyl alcohol on CYPlBl-mediated estradiol 
hydroxylation. 
Perillyl alcohol mainly inhibited both CYPIBI-mediated 4-hydroxylation 




II. Kinetics assays of chalcones on CYPlAl & CYPIBI microsomes induced 
estradiol-hydroxylation 
In each reaction, estradiol (1-100 fiM) was incubated with 10 praol human 
recombinant CYPlAl/lBl microsomes, and different concentrations of chalcones 
(0-10 |iM), the HPLC assay was carried out as described in Materials and Methods 
and the estradiol metabolites were determined by a U V detector at 230 nm (Figure 
6.4). 
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Kinetic study of chalcone on CYPlBl-mediated estradiol hydroxylation 
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6.4A-3 
Kinetic study of chalcone on CYPlBl-mediated estradiol hydroxylation 
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Figure 6.4A-2&3—Chalcone decreased CYPIBI mediated 4-hy(iroxyestradiol 





Kinetic study of 2'-hydroxychalcone on CYPlAl-mediated estradiol hydroxylation 
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Figure 6.4B—2'-Hydroxychalcone decreased CYPlAl-mediated 
2-hydroxyIation. 
2' -Hydroxychaclone significantly decreased CYPlAl-mediated 
2-hydroxyestradiol production in a dose-dependent manner, especially at 




Kinetic study of 2-hydroxychalcone on CYPlAl-mediated estradiol hydroxylation 
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Figure 6.4C-1一2-Hydroxychalcone increased CYPlAl-mediated 
2-hydroxyestradiol formation，especially at 5 |_iM. 
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Figure 6.4C-2一2-Hydroxychalcone decreased CYPl A1-mediated 16 a 
-hydroxyestradiol formation at low concentrations, but it increased 16 a 




Kinetic study of 2-hydroxychalcone on CYPlBl-mediated estradiol hydroxylation 
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Figure 6.4C-3—2-Hydroxy chalcone significantly decreased 
CYPlBl-mediated 4-hydroxylation. 





Kinetic study of butein on CYPlBl-mediated estradiol hydroxylation 
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Figure 6.4D-1—Butein decreased CYPIBI-mediated 4-hydroxyestradiol 
formation in a concentration-dependent manner. 
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Figure 6.4D-2一Butein significantly decreased CYPIBI-mediated 16 a 
-hydroxyestradiol formation in a concentration-dependent maimer, especially for 
concentrations higher than 0.5 fiM. 
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in. Chalcones suppressed estradiol-hydroxylase activities in MCF-7 cells 
Chalcones significantly suppressed estradiol 4- & 2 -hydroxylase activities in 
MCF-7 cells. Among them, chalcone (Figure 6.5A) and 2'-hydroxychalcone (Figure 
6.5B) decreased nearly 70% of estradiol 4-hyclroxylase activity in MCF-7 cells at the 
concentration of 5 joM. While 4,2‘,4'-trihydroxychalcone (Figure 6.5D) and butein 
(Figure 6.5E) displayed a 90% inhibition of both estradiol 4- & 2 -hydroxylase 
activities. 
6.5A 
Estradiol-hydroxylation in MCF-7 cells 
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6.5B 
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Figure 6.5一Estradiol-hydroxylation assay treated with chalcones in MCF-7 
cells. 
6.5A: Chalcone; 6.5B: 2‘-Hydroxychaicone； 6.5C: 2-Hydroxychalcone; 
6.5D: 4,2',4'-Trihydroxychalcone; 6.5E: Butein 
MCF-7 cells were seeded in 6-well plates. After 1 day incubation at 37 the 
cells were treated with 1 |iM D M B A and chalcones with different concentrations for 
24 h. Then 10 |_iM estradiol was administered. 8 h later the medium was recovered 
and treated with p-glucuronidase (3,000 units / ml, PH 5.0) for another 18 h. Cells 
were harvested and washed by PBS (PH 7.4). Cell lysate protein content was 
determined. The estradiol metabolites were extracted twice by ethyl acetate and then 
dissolved in methanol, and filtered. The hydroxyestradiols were separated and 
measured by a HPLC method as described above. 
6.5C 
Effects of 2-hydroxychalcone on estradiol-
hydroxylation in MCF-7 cells 
7 -
§ . j： —4-hydroxyestradiol 
J 2-hydroxyestradiol 
I! f \ 
If 
^ 1 - X 银 T 
工 ™ HS 
0 H— 1 1 1 —r 1 1 
0 1 2 3 4 5 6 
'2-Hydroxychalcone] |JM 
2-Hydroxychalcone significantly decreased estradiol 2 -hydroxylase activity 
with a dose-dependent manner in MCF-7 cells, but it didn't show any trend in the 




Effects of 4,2',4'-trihydroxychalcone on estradiol-
^ hydroxylation in MCF-7 cells 
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4,2',4' -Trihydroxychalcone significantly decreased both estradiol 2- & 4 
-hydroxylase activities by >90% in a dose-dependent manner in MCF-7 cells. 
Values are means ±SE，n=3. 
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Butein significantly decreased both estradiol 2- & 4 -hydroxylase activities by 
>90% with a dose dependent manner in MCF-7 cells. Values are means 土SE, n=3. 
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Part Four Discussion 
Estradio 1-hydroxylation is closely related to cancer risk. Estradiol (E2) is 
metabolized into estrone (Ei), 2-hydroxyestradiol (2-OHE2), 4-hydroxyestradiol 
(4-OHE2), 16a-hydroxyestradiol (16a-OHE2) and many other metabolites (Cheng et 
al., 2001). Previous studies have demonstrated that treatment of MCF-7 breast cancer 
cells with environmental pollutant PAHs results in greater than 10-fold increases in 
the rates of estradiol 4- and 2-hydroxylation. The 4-hydroxy metabolite of 
17|3-estradiol has been implicated in the carcinogenicity of this hormone (Hayes et al.， 
1996). In the previous study, 2-hydroxychalcone, 4,2',4'-trihydroxychalcone, butein 
and perillyl alcohol had been demonstrated to be specific CYPIBI inhibitors. In this 
section, their effects on estradiol metabolizing pathways were also investigated. 
In human breast cancer MCF-7 cells, the formation of 4-OHE2 is catalyzed by 
cytochrome CYPIBI (Liehr & Ricci，1996). It has been confirmed that CYPIBI is a 
highly selective estradiol 4-hydroxylase (Murray et al., 2001). However, in the present 
study, CYPIBI was found to metabolize estradiol into 2-OHE2 and 16a-OHE2 in 
addition to 4-OHE2. CYPlAl predominantly catalyzed estradiol into 2-OHE2 with a 
small portion of 4-OHE2 and 16a-OHE2. 
One approach to lower the estrogenic effect is to regulate the enzymes involved 
in the biosynthesis and interconversion of the biologically potent estrogen. Since the 
2- and 16a-hy(lroxylations are largely mutually exclusive, therefore, any drug that 
increases the 2-hydroxylation reaction can decrease the estrogeriic effects; it thus 
lowers the risk of breast cancer (Wong et al” 1998). Based on this study, perillyl 
alcohol significantly decreased 4- & 16a-hydroxyIation of estradiol, which was the 
result of its inhibition on CYPIBI enzyme activity. This was also a mechanism of its 
anti-carcinogenesis effect. However, it also decreased CYPlAl-mediated 
2-hydroxylation of estradiol. 
At the kinetic level, the unsubstituted chalcone showed a concentration 
dependent inhibition on 4-, 2- and 16a-hydroxylation of estradiol, so did 
2'-hydroxychalcone on 2-hydroxylation of estradiol. Their inhibitory effects on CYPl 
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enzyme actiWties contributed to the hydroxylation pattern. 2-Hydroxychalcone 
increased CYPl A1-mediated 2-hydroxylation of estradiol, while decreased 
CYPlBl-mediated 4-hydroxylation of estradiol. The characteristics suggested its 
potency in protection against estradiol-induced carcinogenesis. A similar effect was 
also observed by butein with decreased 4- & 16a-OHE2 levels. 
In in vivo models, estrogens bind to estrogen receptors, and initiate gene 
expression to regulate the cell cycle and cell proliferation (Hiraku et al.，2001). It is 
generally accepted that 2-hydroxylation lowers the estrogenicity of estradiol, whereas 
the 4- and 16a-hydroxy metabolites may activate estrogen receptor and may be 
transformed into DNA- and protein-reactive species presumably involved in 
tumorigenesis at estrogen dependent sites (Ritter et al., 2001). 
In MCF-7 cells, chalcone and 2‘ -hydroxychalcone dose-dependently decreased 
4-OHE2, which was consistent with their inhibitory properties on CYPIBI enzyme. 
2-Hydroxychalcone dose-dependently decreased 2-OHE2 but not 4-OHE2 in MCF-7 
cells. However, results in the previous study didn't demonstrate its inhibition on 
CYPlAl enzyme. In contrast, 4,2',4'-trihydroxychalcone and butein could decrease 
both 2-OHE2 and 4-OHE2 without inhibiting CYPlAl enzyme. 
In summary, chalcones and perillyl alcohol could regulate estrogen metabolizing 
pathways, which could be an alternative mechanism for their chemopreventive 
properties. Whether the effects occurred at the CYPl enzyme level or estrogen 
receptor level still needs further investigation. 
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CHAPTER 7 SUMMARY 
In the present research, the effects of chalcones, perillyl alcohol, limonene and 
lycopene on CYPlAl & IBl and UGT enzyme activities in the human breast cancer 
cell line MCF-7 and the liver cell line HepG2 were investigated. The results indicated 
that all the phytochemicals could modulate drug metabolizing enzymes in various 
extents. 
I . Chalcones displayed inhibitory effects on DMBA-induced carcinogenesis 
At the enzyme level, the six chalcones except 2-hydroxychalcone showed 
combined inhibition on CYPlAl/lBl enzyme activities in intact MCF-7 cells with 
IC50S ranging from 0.04 jiM to 0.4 jiM. Chalcone and three mono-hydroxylated 
chalcones competitively or noncompetitively inhibited both CYPlAl & IBl enzyme 
activities, while 4,2‘,4‘-trihydroxychalcone and butein only inhibited CYPIBI 
enzyme activity. 
At the gene transcription level, chalcone and 2' -hydroxychalcone significantly 
decreased both CYPlAl & IBl m R N A in a concentration-dependent manner. 
2-Hydroxychalcone and 4,2‘,4'-trihydroxychalcone reduced CYPIBI m R N A without 
affecting CYPlAl mRNA. 4-Hydroxychalcone and butein slightly induced CYPlAl 
m R N A and didn't show any suppression on CYPIBI m R N A until reaching the 
concentration of 10 |iM. 
The induction of U G T enzyme by chalcones is another pathway to protect 
against chemical carcinogenesis. 
Chalcone, 2-hydroxychalcone, 4,2' ,4' -trihydroxychalcone and butein were 
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inhibitory on DMBA-induced estradiol 2，4- & 16 a -hydroxylation in MCF-7 cells. 
In summary, chalcones inhibited DMBA-induced D N A damage by modulating 
Phase I and Phase n enzymes, and estradiol hydroxylation pathways. The 
chemopreventive properties of chalcones to a certain extent could be predicted by 
their chemical structures, especially the number and position of the hydroxy 
substitutions. 
II. Perillyl alcohol and limonene modulated DMBA-induced carcinogenesis 
Perillyl alcohol protected D M B A - D N A adduct formation by inhibiting CYPlAl 
& IBl enzymes and inducing UGT enzymes. It also inhibited estradiol hydroxylation 
in MCF-7 cells. Limonene showed less inhibitory effects on CYPlAl & IBl 
enzymes than that of perillyl alcohol. This difference might be attributed to the 
additional hydroxy group in the structure of perillyl alcohol. 
HI. Lycopene also possessed chemproventive properties 
Lycopene was another potent inhibitor of CYPlAl & IBl enzymes in MCF-7 
cells, it also displayed inducing effect on UGT enzymes. Lycopene could protect 
against DMBA-induced D N A damage by regulating both Phase I and Phase n 
enzyme pathways. 
In summary, chalcones, perillyl alcohol, limonene and lycopene were all potent 
chemopreventive compounds. Their protective effects against PAH-induced 
carcinogenesis could involve at different pathways, and their potencies were 
determined by their chemical structures. 
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APPENDIX 1 ABBREVIATIONS 
AhR Aryl hydrocarbon receptor 
ARNT Aryl hydrocarbon receptor nuclear translocator 
Butein 3,4,2' ,4'-Tetrahydroxychalcone 
< 
CYP or P450 Cytochrome P450 
D M B A 7，12-Dimethylbenz[a]anthracene 
D M S O Dimethyl sulfoxide 
Ez 17p-Estradiol 
EROD Ethoxyresomfin-O-deethylase 
FBS Fetal bovine serum 
HPLC High-performance liquid chromatography 
Hsp90 Heat shock protein 90 
Isoliquirtigenin 4,2',4'-Trihydroxychalcone 
M T T 3"(4,5 Dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide 
PAH Polycyclic aromatic hydrocarbons 
PBS Phosphate-buffered saline 
PGR Polymerase chain reaction 
RT-PCR Reversed transcription - polymerase chain reaction 
U D P G A Uridine 5 ‘ -diphospho-glucuronic Acid 
UGT Uridine diphospho-glucuronosyltransferase 
UGTlAl Uridine diphospho-glucuronosyltransferase lAl 
XRE Xenobiotics responsive element 
P-NADPH p-Nicotinamide adenine dinucleotide phosphate, reduced form 
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APPENDIX 2 REAGENTS 
Name Components 
lOx dNTP solution 2.5 m M dATP, dCTP, dGTP, dTTP ： 
lOx PGR buffer 200 m M Tris-Cl pH8.4 at 23T, 500 m M KCl, 25 
m M MgCl2 
buffer 50 m M Tris-HCl (pH 7.5)，250 m M NaCl, 5 m M 
(mammalian) EDTA, 50 m M NaF，0.2% v/v Nonidet P-40 
LB medium 1 % w/v tryptone, 0.5 % w/v yeast extracts, 1 % w/v 
NaCl 
LB plate LB medium, 1.5 % w/v agar 
LB'^P medium LB medium, 100 |ig/ml ampicilin 
LB 咖P plate LB medium, 1.5% w/v agar, 200 \xg/ ml ampicilin 
"Pl 50 m M Tris-Cl (pH 8.0)，10 m M EDTA, 10% w/v 
RNaseA 
~P2 200 m M NaOH, 1% w/v SDS 
"P3 3 M KOAc, pH 5.5 
"PBS 0.8% w/v NaCl, 0.02% w/v KCl, 0.08% w/v 
Na2HP04*2H20. 0.02% w/v KH2PO4 
Protease inhibitors 1 m M PMSF，0.1% w/v leupeptin, 0.2% w/v 
aprotinin, 1% w/v soybean trypsin inhibitor, 1.5% 
w/v benzaiTiidine, 1% w/v chymostatin, 1% w/v 
pep statin 
-QBT 750 m M NaCl, 50 m M MOPS (pH 7.0)，15% v/v 
isopropanol, 0.15% v/v Triton X-100 
1 M NaCl, 50 m M MPOS (pH 7.0), 15% v/v 
isopropanol 
1.25 M NaCl, 50 m M Tris-Cl (pH 8.5)，15% v/v 
isopropanol 




TAE buffer 40 m M Tris-OAc (pH 8.0)，40 m M HOAc, 2 m M 
EDTA 
"TE 10 m M Tris-Cl (pH 8.0), 1 m M EDTA “ 
*The components of all homemade reagents are listed. For the commercially 
purchased reagents, please refer to the manufacturers' manual, 
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APPENDIX 3 PRIMERS 
Code Sequence 
p-actin Forward 5'- GTGGGGCGCCCCAGGCACCA -3’ . 
P-actin Reverse 5，- CTCCTTAATGTCACGCACGATTTC -3' 
CYP1A1 Forward 5 ’ - TAG AC ACTG ATCTGGCTGCAG -3 ’ 
CYPlAl Reverse 5’- GGGAAGGCTCCATCAGCATC -3' 
CYPIBI Forward 5’- AACGTCATGAGTGCCGTGTGT-3’ 
CYPIBI Reverse 5’- GGCCGGTACGTTCTCCAAATC -3’ 
UGTlAl Forward 5'- AACAAGGAGCTCATGGCCTCC -3’ 
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